Gene Symbol | Gene ID | Gene Info |
---|---|---|
Foxa3
|
ENSMUSG00000040891.5 | forkhead box A3 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr7_19016148_19016302 | Foxa3 | 7313 | 0.074015 | 0.67 | 2.1e-08 | Click! |
chr7_19023386_19024051 | Foxa3 | 180 | 0.783493 | 0.48 | 2.0e-04 | Click! |
chr7_19022673_19022857 | Foxa3 | 773 | 0.357978 | 0.12 | 3.9e-01 | Click! |
chr7_19022292_19022469 | Foxa3 | 1158 | 0.232209 | 0.10 | 4.5e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr12_111516879_111517219 | 16.59 |
Gm40578 |
predicted gene, 40578 |
16209 |
0.1 |
chr11_87750589_87750762 | 15.57 |
Mir142hg |
Mir142 host gene (non-protein coding) |
4902 |
0.1 |
chr8_40572970_40573513 | 14.04 |
Mtmr7 |
myotubularin related protein 7 |
17273 |
0.16 |
chr1_189756746_189757047 | 13.59 |
Ptpn14 |
protein tyrosine phosphatase, non-receptor type 14 |
28621 |
0.16 |
chr7_103826228_103826489 | 13.04 |
Hbb-bs |
hemoglobin, beta adult s chain |
1367 |
0.17 |
chr5_109557850_109558797 | 13.02 |
Crlf2 |
cytokine receptor-like factor 2 |
613 |
0.67 |
chr19_43999221_43999522 | 12.86 |
Cpn1 |
carboxypeptidase N, polypeptide 1 |
12815 |
0.14 |
chr3_116614535_116614842 | 12.56 |
Trmt13 |
tRNA methyltransferase 13 |
101 |
0.92 |
chr8_23053611_23053959 | 12.33 |
Ank1 |
ankyrin 1, erythroid |
4474 |
0.2 |
chr13_37715025_37715360 | 12.26 |
Gm40918 |
predicted gene, 40918 |
1119 |
0.39 |
chr13_47250640_47250987 | 11.90 |
Rnf144b |
ring finger protein 144B |
56988 |
0.11 |
chr16_76323171_76323322 | 11.63 |
Nrip1 |
nuclear receptor interacting protein 1 |
412 |
0.88 |
chr4_137651076_137651230 | 11.51 |
Usp48 |
ubiquitin specific peptidase 48 |
852 |
0.58 |
chr11_116506385_116506879 | 11.18 |
Rpl36-ps1 |
ribosomal protein L36, pseudogene 1 |
2096 |
0.17 |
chr1_134460444_134460597 | 11.13 |
Klhl12 |
kelch-like 12 |
4965 |
0.12 |
chr19_34657030_34657217 | 11.11 |
Ifit1 |
interferon-induced protein with tetratricopeptide repeats 1 |
16252 |
0.11 |
chr13_107101149_107101349 | 11.10 |
Gm31452 |
predicted gene, 31452 |
37554 |
0.14 |
chr1_84278451_84278658 | 10.73 |
Pid1 |
phosphotyrosine interaction domain containing 1 |
5869 |
0.27 |
chr3_83020261_83020784 | 10.73 |
Fga |
fibrinogen alpha chain |
5554 |
0.15 |
chr1_16653322_16653502 | 10.64 |
Eloc |
elongin C |
3213 |
0.15 |
chr4_139335168_139335391 | 10.64 |
AL807811.1 |
aldo-keto reductase family 7 member A2 (AKR7A2) pseudogene |
1901 |
0.15 |
chr15_102395443_102395620 | 10.52 |
Sp1 |
trans-acting transcription factor 1 |
10612 |
0.09 |
chr2_29677911_29678077 | 10.24 |
Rapgef1 |
Rap guanine nucleotide exchange factor (GEF) 1 |
24488 |
0.15 |
chr6_38443950_38444228 | 10.18 |
Ubn2 |
ubinuclein 2 |
3556 |
0.2 |
chr13_81325947_81326099 | 10.14 |
Adgrv1 |
adhesion G protein-coupled receptor V1 |
16813 |
0.25 |
chr9_54571273_54571435 | 10.09 |
Cib2 |
calcium and integrin binding family member 2 |
11136 |
0.16 |
chr10_84639605_84639777 | 9.95 |
Polr3b |
polymerase (RNA) III (DNA directed) polypeptide B |
595 |
0.69 |
chr1_153988420_153988604 | 9.95 |
Gm29291 |
predicted gene 29291 |
17705 |
0.14 |
chr4_128669269_128669559 | 9.94 |
Phc2 |
polyhomeotic 2 |
14676 |
0.17 |
chr8_123957515_123957666 | 9.94 |
Gm45890 |
predicted gene 45890 |
5067 |
0.12 |
chr8_109586960_109587627 | 9.93 |
Dhodh |
dihydroorotate dehydrogenase |
6758 |
0.14 |
chr16_17638547_17638739 | 9.90 |
Smpd4 |
sphingomyelin phosphodiesterase 4 |
56 |
0.95 |
chr12_105824762_105825098 | 9.90 |
Papola |
poly (A) polymerase alpha |
4137 |
0.21 |
chr1_88206786_88207160 | 9.80 |
Dnajb3 |
DnaJ heat shock protein family (Hsp40) member B3 |
1191 |
0.22 |
chr15_81530960_81531122 | 9.72 |
Gm5218 |
predicted gene 5218 |
31496 |
0.1 |
chr1_191994757_191994932 | 9.68 |
Gm32460 |
predicted gene, 32460 |
1983 |
0.2 |
chr11_49085014_49085190 | 9.64 |
Ifi47 |
interferon gamma inducible protein 47 |
1598 |
0.18 |
chr18_32138140_32138298 | 9.47 |
Proc |
protein C |
20 |
0.96 |
chr16_49896195_49896504 | 9.44 |
Cd47 |
CD47 antigen (Rh-related antigen, integrin-associated signal transducer) |
29516 |
0.24 |
chr1_132389850_132390483 | 9.36 |
Tmcc2 |
transmembrane and coiled-coil domains 2 |
152 |
0.94 |
chr1_187155725_187155876 | 9.32 |
Spata17 |
spermatogenesis associated 17 |
12703 |
0.15 |
chr7_45708987_45709454 | 9.23 |
Dbp |
D site albumin promoter binding protein |
1331 |
0.17 |
chr15_68972366_68972545 | 9.13 |
Gm49422 |
predicted gene, 49422 |
12924 |
0.24 |
chr7_73517907_73518068 | 9.06 |
C130083A15Rik |
RIKEN cDNA C130083A15 gene |
10738 |
0.11 |
chr7_141628110_141628282 | 8.98 |
Mir7063 |
microRNA 7063 |
7495 |
0.13 |
chr11_109822407_109822575 | 8.97 |
1700012B07Rik |
RIKEN cDNA 1700012B07 gene |
5531 |
0.18 |
chr18_84885392_84885727 | 8.94 |
Cyb5a |
cytochrome b5 type A (microsomal) |
7958 |
0.17 |
chr10_21444559_21444841 | 8.91 |
Gm48386 |
predicted gene, 48386 |
936 |
0.49 |
chr10_53930227_53930492 | 8.89 |
Man1a |
mannosidase 1, alpha |
46756 |
0.16 |
chr18_21152139_21152308 | 8.88 |
Gm6378 |
predicted pseudogene 6378 |
75114 |
0.09 |
chr9_7869236_7869495 | 8.88 |
Birc3 |
baculoviral IAP repeat-containing 3 |
3492 |
0.23 |
chr3_10021654_10021824 | 8.85 |
Gm38335 |
predicted gene, 38335 |
3800 |
0.2 |
chr7_50105720_50105871 | 8.83 |
Nell1 |
NEL-like 1 |
7485 |
0.32 |
chr2_30319386_30319558 | 8.80 |
Gm14471 |
predicted gene 14471 |
4514 |
0.11 |
chr15_41846165_41846316 | 8.79 |
Oxr1 |
oxidation resistance 1 |
3984 |
0.24 |
chr14_60257239_60257405 | 8.79 |
Gm49336 |
predicted gene, 49336 |
5815 |
0.14 |
chr11_90676147_90676490 | 8.76 |
Tom1l1 |
target of myb1-like 1 (chicken) |
11261 |
0.2 |
chr10_4625371_4625599 | 8.72 |
Esr1 |
estrogen receptor 1 (alpha) |
13464 |
0.23 |
chr4_137077410_137077701 | 8.72 |
Zbtb40 |
zinc finger and BTB domain containing 40 |
28754 |
0.12 |
chr6_115651057_115651343 | 8.69 |
Gm14335 |
predicted gene 14335 |
12141 |
0.11 |
chr3_146655388_146655585 | 8.69 |
4930503B20Rik |
RIKEN cDNA 4930503B20 gene |
4169 |
0.15 |
chr4_141131586_141132124 | 8.67 |
Szrd1 |
SUZ RNA binding domain containing 1 |
7872 |
0.11 |
chr14_76733384_76733551 | 8.65 |
4930431P22Rik |
RIKEN cDNA 4930431P22 gene |
26664 |
0.17 |
chr7_19685403_19685697 | 8.65 |
Apoc4 |
apolipoprotein C-IV |
4071 |
0.08 |
chr7_19841889_19842046 | 8.60 |
Gm44658 |
predicted gene 44658 |
5006 |
0.08 |
chr18_21373522_21373870 | 8.58 |
Gm22886 |
predicted gene, 22886 |
7235 |
0.2 |
chr6_112684189_112684354 | 8.56 |
Rad18 |
RAD18 E3 ubiquitin protein ligase |
8495 |
0.22 |
chr4_136008870_136009042 | 8.55 |
Gm13008 |
predicted gene 13008 |
5390 |
0.1 |
chr17_27980503_27980792 | 8.52 |
Gm49802 |
predicted gene, 49802 |
1745 |
0.24 |
chr10_117106272_117106596 | 8.51 |
Frs2 |
fibroblast growth factor receptor substrate 2 |
24412 |
0.12 |
chr1_64733185_64733406 | 8.47 |
Gm38058 |
predicted gene, 38058 |
2945 |
0.21 |
chr2_71083882_71084235 | 8.45 |
Dcaf17 |
DDB1 and CUL4 associated factor 17 |
8716 |
0.2 |
chr16_76323639_76324221 | 8.41 |
Nrip1 |
nuclear receptor interacting protein 1 |
272 |
0.94 |
chr6_144201763_144201915 | 8.39 |
Sox5 |
SRY (sex determining region Y)-box 5 |
2218 |
0.46 |
chr5_100899819_100900094 | 8.39 |
Gm36793 |
predicted gene, 36793 |
13751 |
0.14 |
chr8_13206364_13206563 | 8.34 |
2810030D12Rik |
RIKEN cDNA 2810030D12 gene |
5643 |
0.11 |
chr5_147299227_147299912 | 8.31 |
Cdx2 |
caudal type homeobox 2 |
7701 |
0.1 |
chr7_126746842_126747128 | 8.25 |
Gm44855 |
predicted gene 44855 |
2570 |
0.09 |
chr12_88984058_88984248 | 8.24 |
Nrxn3 |
neurexin III |
30754 |
0.23 |
chr12_103737920_103738559 | 8.24 |
Serpina1b |
serine (or cysteine) preptidase inhibitor, clade A, member 1B |
81 |
0.95 |
chr17_79891950_79892297 | 8.19 |
Atl2 |
atlastin GTPase 2 |
3928 |
0.21 |
chr5_90560713_90561116 | 8.18 |
Albfm1 |
albumin superfamily member 1 |
193 |
0.9 |
chr4_12087867_12088383 | 8.15 |
Tmem67 |
transmembrane protein 67 |
118 |
0.93 |
chr14_56620524_56620699 | 8.10 |
Gm16573 |
predicted gene 16573 |
98 |
0.96 |
chr4_129386351_129386502 | 8.10 |
Gm12980 |
predicted gene 12980 |
6582 |
0.12 |
chr9_116389002_116389158 | 8.09 |
D730003K21Rik |
RIKEN cDNA D730003K21 gene |
57912 |
0.15 |
chr14_48475621_48476075 | 8.07 |
Tmem260 |
transmembrane protein 260 |
3526 |
0.2 |
chr4_150853712_150854009 | 8.07 |
Errfi1 |
ERBB receptor feedback inhibitor 1 |
59 |
0.94 |
chr2_110005965_110006151 | 8.07 |
Lgr4 |
leucine-rich repeat-containing G protein-coupled receptor 4 |
5530 |
0.21 |
chr6_82072895_82073274 | 8.05 |
Gm15864 |
predicted gene 15864 |
20503 |
0.16 |
chr17_48019582_48020013 | 8.03 |
Gm14871 |
predicted gene 14871 |
16225 |
0.12 |
chr11_57960034_57960300 | 8.03 |
Gm12245 |
predicted gene 12245 |
11082 |
0.15 |
chr1_127756304_127756509 | 8.02 |
Acmsd |
amino carboxymuconate semialdehyde decarboxylase |
351 |
0.86 |
chr17_81176001_81176176 | 8.02 |
Gm50042 |
predicted gene, 50042 |
70650 |
0.11 |
chr18_24102564_24102822 | 8.00 |
Ino80c |
INO80 complex subunit C |
12220 |
0.18 |
chr9_57762816_57763031 | 7.99 |
Clk3 |
CDC-like kinase 3 |
1385 |
0.34 |
chr7_135815808_135816144 | 7.90 |
6330420H09Rik |
RIKEN cDNA 6330420H09 gene |
37706 |
0.12 |
chr11_37412938_37413250 | 7.89 |
Tenm2 |
teneurin transmembrane protein 2 |
177130 |
0.03 |
chr1_105114814_105115093 | 7.86 |
Gm29012 |
predicted gene 29012 |
1501 |
0.53 |
chr17_12378400_12378705 | 7.85 |
Plg |
plasminogen |
56 |
0.97 |
chr11_57954565_57954743 | 7.82 |
Gm12245 |
predicted gene 12245 |
5569 |
0.17 |
chr11_87701431_87701582 | 7.77 |
1110028F11Rik |
RIKEN cDNA 1110028F11 gene |
110 |
0.92 |
chr13_24419481_24419859 | 7.77 |
Cmah |
cytidine monophospho-N-acetylneuraminic acid hydroxylase |
2446 |
0.22 |
chr13_106998386_106998537 | 7.73 |
Kif2a |
kinesin family member 2A |
1705 |
0.27 |
chr2_30417599_30417778 | 7.71 |
Ptpa |
protein phosphatase 2 protein activator |
1386 |
0.24 |
chr8_94354649_94354841 | 7.67 |
Slc12a3 |
solute carrier family 12, member 3 |
301 |
0.82 |
chr6_5287440_5287910 | 7.67 |
Pon2 |
paraoxonase 2 |
1393 |
0.4 |
chr11_57956307_57956458 | 7.66 |
Gm12245 |
predicted gene 12245 |
7297 |
0.16 |
chr7_119748906_119749057 | 7.64 |
Gm44966 |
predicted gene 44966 |
3696 |
0.12 |
chr5_149108183_149108514 | 7.63 |
Mm2pr |
macrophage M2 polarization regulator |
15064 |
0.1 |
chr4_149149680_149149897 | 7.63 |
Rpsa-ps12 |
ribosomal protein SA, pseudogene 12 |
6400 |
0.12 |
chrX_56446670_56446966 | 7.62 |
Gm2174 |
predicted gene 2174 |
1147 |
0.35 |
chr19_4569314_4569621 | 7.61 |
Pcx |
pyruvate carboxylase |
10657 |
0.13 |
chr5_118302779_118303125 | 7.60 |
Gm25076 |
predicted gene, 25076 |
36503 |
0.14 |
chr13_109647928_109648108 | 7.59 |
Pde4d |
phosphodiesterase 4D, cAMP specific |
15238 |
0.31 |
chr8_111312693_111312982 | 7.55 |
Mlkl |
mixed lineage kinase domain-like |
3282 |
0.18 |
chr5_76063456_76063845 | 7.55 |
Gm6051 |
predicted gene 6051 |
2887 |
0.24 |
chr3_146570551_146570710 | 7.54 |
Uox |
urate oxidase |
204 |
0.91 |
chr13_104641151_104641346 | 7.54 |
2610204G07Rik |
RIKEN cDNA 2610204G07 gene |
43683 |
0.19 |
chr8_109986412_109986663 | 7.54 |
Tat |
tyrosine aminotransferase |
3900 |
0.15 |
chr2_52604368_52604541 | 7.50 |
Bloc1s2-ps |
biogenesis of lysosomal organelles complex-1, subunit 2, pseudogene |
15300 |
0.2 |
chr4_130297144_130297500 | 7.49 |
Fabp3 |
fatty acid binding protein 3, muscle and heart |
11273 |
0.14 |
chr14_121355790_121356113 | 7.46 |
Stk24 |
serine/threonine kinase 24 |
3917 |
0.25 |
chr2_27624746_27625249 | 7.46 |
Rxra |
retinoid X receptor alpha |
51443 |
0.12 |
chr11_4659908_4660076 | 7.45 |
Ascc2 |
activating signal cointegrator 1 complex subunit 2 |
22245 |
0.12 |
chr10_37231291_37231825 | 7.44 |
4930543K20Rik |
RIKEN cDNA 4930543K20 gene |
32190 |
0.19 |
chr4_120665266_120665476 | 7.43 |
Cited4 |
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 4 |
1201 |
0.41 |
chr10_8087179_8087372 | 7.42 |
Gm48614 |
predicted gene, 48614 |
65983 |
0.11 |
chr14_34240754_34241041 | 7.42 |
Gm49201 |
predicted gene, 49201 |
9169 |
0.09 |
chr9_58658697_58658848 | 7.41 |
Rec114 |
REC114 meiotic recombination protein |
520 |
0.78 |
chr6_144652995_144653148 | 7.37 |
Sox5it |
SRY (sex determining region Y)-box 5, intronic transcript |
19649 |
0.18 |
chr2_103960113_103960268 | 7.37 |
Lmo2 |
LIM domain only 2 |
2195 |
0.24 |
chr7_68696957_68697312 | 7.37 |
Gm44692 |
predicted gene 44692 |
29333 |
0.18 |
chr12_79799402_79799702 | 7.37 |
9430078K24Rik |
RIKEN cDNA 9430078K24 gene |
125181 |
0.05 |
chr8_14889769_14890087 | 7.36 |
Cln8 |
CLN8 transmembrane ER and ERGIC protein |
569 |
0.76 |
chr11_83286312_83286488 | 7.36 |
Slfn14 |
schlafen 14 |
326 |
0.76 |
chr13_100532853_100533064 | 7.33 |
Ocln |
occludin |
19502 |
0.11 |
chr17_50389526_50389678 | 7.31 |
Gm49906 |
predicted gene, 49906 |
50350 |
0.14 |
chr19_45113881_45114037 | 7.28 |
Gm35867 |
predicted gene, 35867 |
10718 |
0.14 |
chr16_32660493_32661316 | 7.28 |
Tnk2 |
tyrosine kinase, non-receptor, 2 |
330 |
0.85 |
chr17_5830620_5830779 | 7.25 |
Gm26622 |
predicted gene, 26622 |
7269 |
0.14 |
chr3_77831850_77832047 | 7.24 |
Gm37576 |
predicted gene, 37576 |
41205 |
0.19 |
chr10_54042474_54042667 | 7.24 |
Gm47917 |
predicted gene, 47917 |
21241 |
0.18 |
chr13_59615643_59615812 | 7.22 |
Naa35 |
N(alpha)-acetyltransferase 35, NatC auxiliary subunit |
2184 |
0.21 |
chr2_127375314_127375491 | 7.22 |
Adra2b |
adrenergic receptor, alpha 2b |
12116 |
0.14 |
chr9_31254711_31255028 | 7.21 |
Gm7244 |
predicted gene 7244 |
19952 |
0.14 |
chr2_9137139_9137290 | 7.20 |
1700061F12Rik |
RIKEN cDNA 1700061F12 gene |
52301 |
0.15 |
chr2_122141411_122141599 | 7.18 |
B2m |
beta-2 microglobulin |
6181 |
0.13 |
chr13_20132090_20132277 | 7.17 |
Elmo1 |
engulfment and cell motility 1 |
20671 |
0.26 |
chr5_142920434_142920596 | 7.15 |
Actb |
actin, beta |
13761 |
0.14 |
chr3_79994303_79994554 | 7.14 |
A330069K06Rik |
RIKEN cDNA A330069K06 gene |
60464 |
0.11 |
chr4_13751233_13751434 | 7.14 |
Runx1t1 |
RUNX1 translocation partner 1 |
36 |
0.99 |
chr12_103863072_103863984 | 7.12 |
Serpina1a |
serine (or cysteine) peptidase inhibitor, clade A, member 1A |
23 |
0.95 |
chr4_104766167_104766351 | 7.11 |
C8b |
complement component 8, beta polypeptide |
58 |
0.98 |
chr17_84777000_84777216 | 7.11 |
Lrpprc |
leucine-rich PPR-motif containing |
435 |
0.81 |
chr15_6059468_6059633 | 7.09 |
Gm8047 |
predicted gene 8047 |
24589 |
0.23 |
chr1_132355108_132355419 | 7.07 |
Tmcc2 |
transmembrane and coiled-coil domains 2 |
9685 |
0.12 |
chr11_5498499_5498660 | 7.06 |
Gm11963 |
predicted gene 11963 |
261 |
0.88 |
chr7_84652058_84652214 | 7.05 |
Zfand6 |
zinc finger, AN1-type domain 6 |
17797 |
0.16 |
chr6_28504713_28504904 | 7.05 |
Snd1 |
staphylococcal nuclease and tudor domain containing 1 |
24379 |
0.13 |
chr15_82794220_82794587 | 7.05 |
Cyp2d26 |
cytochrome P450, family 2, subfamily d, polypeptide 26 |
109 |
0.93 |
chr1_37041206_37041380 | 7.05 |
Vwa3b |
von Willebrand factor A domain containing 3B |
5585 |
0.2 |
chr19_34212929_34213142 | 7.04 |
Stambpl1 |
STAM binding protein like 1 |
4399 |
0.2 |
chr6_146630401_146630566 | 7.03 |
Tm7sf3 |
transmembrane 7 superfamily member 3 |
4015 |
0.16 |
chr19_17328336_17328491 | 7.01 |
Gcnt1 |
glucosaminyl (N-acetyl) transferase 1, core 2 |
7023 |
0.23 |
chr10_118581520_118581685 | 7.00 |
Ifngas1 |
Ifng antisense RNA 1 |
25077 |
0.2 |
chr2_84059555_84059735 | 6.94 |
Gm13692 |
predicted gene 13692 |
25032 |
0.14 |
chr14_86741829_86742153 | 6.94 |
Diaph3 |
diaphanous related formin 3 |
6853 |
0.26 |
chr14_47535141_47535739 | 6.93 |
Gm49004 |
predicted gene, 49004 |
6540 |
0.13 |
chr15_100411166_100411351 | 6.91 |
Slc11a2 |
solute carrier family 11 (proton-coupled divalent metal ion transporters), member 2 |
7836 |
0.11 |
chr1_174907682_174907855 | 6.91 |
Grem2 |
gremlin 2, DAN family BMP antagonist |
14051 |
0.29 |
chr6_72272236_72272936 | 6.90 |
Sftpb |
surfactant associated protein B |
32024 |
0.11 |
chr12_21201642_21201794 | 6.89 |
AC156032.1 |
|
45605 |
0.11 |
chr4_126155903_126156318 | 6.85 |
Sh3d21 |
SH3 domain containing 21 |
6491 |
0.11 |
chr1_161750684_161751022 | 6.85 |
Gm5049 |
predicted gene 5049 |
4797 |
0.17 |
chr7_142535883_142536202 | 6.85 |
Mrpl23 |
mitochondrial ribosomal protein L23 |
62 |
0.95 |
chr11_20395944_20396115 | 6.84 |
Gm12034 |
predicted gene 12034 |
50383 |
0.12 |
chr2_32361053_32361204 | 6.81 |
Ciz1 |
CDKN1A interacting zinc finger protein 1 |
1882 |
0.17 |
chr11_49713043_49713524 | 6.80 |
Cnot6 |
CCR4-NOT transcription complex, subunit 6 |
560 |
0.67 |
chr17_47439741_47439945 | 6.79 |
1700001C19Rik |
RIKEN cDNA 1700001C19 gene |
2467 |
0.17 |
chr5_123223029_123223358 | 6.76 |
Psmd9 |
proteasome (prosome, macropain) 26S subunit, non-ATPase, 9 |
4997 |
0.12 |
chr13_101661667_101661861 | 6.69 |
Pik3r1 |
phosphoinositide-3-kinase regulatory subunit 1 |
30579 |
0.17 |
chr8_36283609_36283970 | 6.68 |
Lonrf1 |
LON peptidase N-terminal domain and ring finger 1 |
34273 |
0.16 |
chr16_18430514_18430668 | 6.67 |
Txnrd2 |
thioredoxin reductase 2 |
1666 |
0.22 |
chr18_53160990_53161142 | 6.65 |
Snx2 |
sorting nexin 2 |
15250 |
0.24 |
chr18_56978164_56978384 | 6.64 |
C330018D20Rik |
RIKEN cDNA C330018D20 gene |
2906 |
0.3 |
chr12_79272716_79273016 | 6.63 |
Zfyve26 |
zinc finger, FYVE domain containing 26 |
4453 |
0.2 |
chr15_3584477_3584653 | 6.63 |
Ghr |
growth hormone receptor |
1073 |
0.6 |
chr12_24879352_24879503 | 6.63 |
Mboat2 |
membrane bound O-acyltransferase domain containing 2 |
47796 |
0.1 |
chr11_85775247_85775913 | 6.61 |
Bcas3os2 |
breast carcinoma amplified sequence 3 opposite strand 2 |
100 |
0.95 |
chr15_3228788_3229300 | 6.59 |
Gm7962 |
predicted gene 7962 |
9346 |
0.2 |
chr11_120980134_120980295 | 6.57 |
Csnk1d |
casein kinase 1, delta |
8589 |
0.1 |
chr1_43413870_43414101 | 6.57 |
Gm29041 |
predicted gene 29041 |
4401 |
0.24 |
chr5_73311488_73311911 | 6.57 |
Gm42732 |
predicted gene 42732 |
335 |
0.78 |
chr15_57906456_57906624 | 6.54 |
Tbc1d31 |
TBC1 domain family, member 31 |
5659 |
0.21 |
chr11_80783625_80783824 | 6.54 |
Myo1d |
myosin ID |
3699 |
0.23 |
chr14_122511582_122511733 | 6.54 |
Gm18143 |
predicted gene, 18143 |
2172 |
0.2 |
chr3_122104059_122104219 | 6.52 |
Abca4 |
ATP-binding cassette, sub-family A (ABC1), member 4 |
15901 |
0.16 |
chr11_79771332_79771811 | 6.51 |
9130204K15Rik |
RIKEN cDNA 9130204K15 gene |
11316 |
0.16 |
chr17_46590528_46590709 | 6.50 |
Ptk7 |
PTK7 protein tyrosine kinase 7 |
17668 |
0.1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.5 | 19.5 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
3.1 | 9.3 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
2.5 | 12.6 | GO:0010612 | regulation of cardiac muscle adaptation(GO:0010612) regulation of cardiac muscle hypertrophy in response to stress(GO:1903242) |
2.5 | 7.5 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
2.5 | 10.0 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
2.4 | 9.6 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
2.4 | 7.1 | GO:0048207 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
2.3 | 7.0 | GO:0048769 | sarcomerogenesis(GO:0048769) |
2.3 | 6.9 | GO:2000327 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
2.2 | 8.9 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
2.2 | 6.5 | GO:2000847 | negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
2.1 | 8.4 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
2.1 | 6.3 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
2.1 | 10.5 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
2.1 | 6.2 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
1.9 | 11.7 | GO:1902222 | L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
1.9 | 7.7 | GO:0000960 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
1.9 | 5.8 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
1.8 | 1.8 | GO:1904502 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
1.8 | 5.5 | GO:1904222 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
1.8 | 5.4 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
1.8 | 5.3 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
1.7 | 5.2 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
1.7 | 10.1 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
1.7 | 11.6 | GO:0034374 | low-density lipoprotein particle remodeling(GO:0034374) |
1.5 | 4.5 | GO:0009093 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
1.5 | 4.4 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
1.5 | 4.4 | GO:0061511 | centriole elongation(GO:0061511) |
1.4 | 2.9 | GO:0032489 | regulation of Cdc42 protein signal transduction(GO:0032489) |
1.3 | 5.3 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
1.3 | 6.6 | GO:0046984 | regulation of hemoglobin biosynthetic process(GO:0046984) |
1.3 | 10.2 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
1.3 | 1.3 | GO:0071233 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
1.3 | 7.6 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
1.3 | 3.8 | GO:1902065 | response to L-glutamate(GO:1902065) |
1.3 | 2.5 | GO:0043974 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
1.2 | 2.5 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
1.2 | 3.7 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
1.2 | 3.7 | GO:2000598 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
1.2 | 3.6 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
1.2 | 6.0 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
1.2 | 3.6 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
1.2 | 4.8 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
1.2 | 4.8 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
1.2 | 9.5 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
1.2 | 2.3 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
1.1 | 5.7 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
1.1 | 4.5 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
1.1 | 4.5 | GO:0070814 | hydrogen sulfide biosynthetic process(GO:0070814) |
1.1 | 3.4 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
1.1 | 4.4 | GO:0015825 | L-serine transport(GO:0015825) |
1.1 | 3.3 | GO:0006768 | biotin metabolic process(GO:0006768) |
1.1 | 5.4 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
1.1 | 3.2 | GO:0003195 | tricuspid valve morphogenesis(GO:0003186) tricuspid valve formation(GO:0003195) |
1.1 | 3.2 | GO:0008228 | opsonization(GO:0008228) |
1.1 | 5.3 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
1.1 | 3.2 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
1.0 | 1.0 | GO:0043300 | regulation of leukocyte degranulation(GO:0043300) |
1.0 | 4.2 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
1.0 | 5.1 | GO:0052805 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
1.0 | 8.1 | GO:0010826 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
1.0 | 5.0 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
1.0 | 3.0 | GO:2001201 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
1.0 | 2.0 | GO:2000705 | regulation of dense core granule biogenesis(GO:2000705) |
1.0 | 2.9 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
1.0 | 5.9 | GO:0034380 | high-density lipoprotein particle assembly(GO:0034380) |
1.0 | 7.7 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.9 | 2.8 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.9 | 1.9 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
0.9 | 2.8 | GO:0021699 | cerebellum maturation(GO:0021590) cerebellar cortex maturation(GO:0021699) |
0.9 | 3.7 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
0.9 | 2.8 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.9 | 0.9 | GO:0006210 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.9 | 1.8 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
0.9 | 1.8 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.9 | 0.9 | GO:1900103 | positive regulation of endoplasmic reticulum unfolded protein response(GO:1900103) |
0.9 | 2.7 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.9 | 2.7 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.9 | 8.9 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
0.9 | 6.2 | GO:0015684 | ferrous iron transport(GO:0015684) |
0.9 | 4.4 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
0.9 | 8.8 | GO:0019627 | urea metabolic process(GO:0019627) |
0.9 | 1.8 | GO:0060696 | regulation of phospholipid catabolic process(GO:0060696) |
0.9 | 2.6 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) |
0.9 | 3.5 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) |
0.9 | 9.5 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.9 | 2.6 | GO:0015819 | lysine transport(GO:0015819) |
0.9 | 5.1 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
0.8 | 5.0 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
0.8 | 3.4 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.8 | 2.5 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.8 | 2.5 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
0.8 | 0.8 | GO:0050713 | negative regulation of interleukin-1 beta secretion(GO:0050713) |
0.8 | 3.3 | GO:0001907 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
0.8 | 0.8 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
0.8 | 4.0 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.8 | 2.4 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.8 | 5.6 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
0.8 | 1.6 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
0.8 | 2.4 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.8 | 3.1 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
0.8 | 6.2 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.8 | 4.6 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.8 | 1.5 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.8 | 2.3 | GO:0009182 | purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) dGDP metabolic process(GO:0046066) |
0.8 | 3.0 | GO:0071286 | cellular response to magnesium ion(GO:0071286) |
0.8 | 2.3 | GO:0009804 | coumarin metabolic process(GO:0009804) |
0.8 | 13.6 | GO:0030488 | tRNA methylation(GO:0030488) |
0.8 | 2.3 | GO:0044789 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
0.7 | 3.0 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.7 | 0.7 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.7 | 2.2 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.7 | 2.2 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
0.7 | 3.7 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.7 | 0.7 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
0.7 | 2.2 | GO:0015744 | succinate transport(GO:0015744) |
0.7 | 2.9 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.7 | 1.4 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.7 | 4.3 | GO:0016266 | O-glycan processing(GO:0016266) |
0.7 | 16.4 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
0.7 | 2.1 | GO:0001905 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
0.7 | 12.6 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.7 | 2.8 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
0.7 | 2.8 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
0.7 | 1.4 | GO:0043691 | reverse cholesterol transport(GO:0043691) |
0.7 | 2.0 | GO:0061084 | negative regulation of protein refolding(GO:0061084) |
0.7 | 2.7 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
0.7 | 4.1 | GO:0034770 | histone H4-K20 methylation(GO:0034770) |
0.7 | 2.0 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.7 | 2.0 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.7 | 2.0 | GO:0007525 | somatic muscle development(GO:0007525) |
0.7 | 2.0 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.7 | 1.3 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.7 | 2.0 | GO:0009730 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.7 | 2.0 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.7 | 0.7 | GO:0060154 | cellular process regulating host cell cycle in response to virus(GO:0060154) |
0.7 | 1.3 | GO:0038109 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.7 | 1.3 | GO:0050711 | negative regulation of interleukin-1 secretion(GO:0050711) |
0.7 | 5.9 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.6 | 22.1 | GO:0006953 | acute-phase response(GO:0006953) |
0.6 | 3.2 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.6 | 1.9 | GO:2000525 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.6 | 1.3 | GO:2000978 | negative regulation of forebrain neuron differentiation(GO:2000978) |
0.6 | 3.2 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.6 | 0.6 | GO:2000383 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.6 | 1.3 | GO:0031652 | positive regulation of heat generation(GO:0031652) |
0.6 | 1.9 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.6 | 1.2 | GO:0046039 | GTP metabolic process(GO:0046039) |
0.6 | 1.2 | GO:0002572 | pro-T cell differentiation(GO:0002572) |
0.6 | 11.7 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.6 | 6.1 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.6 | 3.1 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.6 | 2.4 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.6 | 2.4 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
0.6 | 3.0 | GO:0009249 | protein lipoylation(GO:0009249) |
0.6 | 1.2 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
0.6 | 3.6 | GO:0046060 | dATP metabolic process(GO:0046060) |
0.6 | 0.6 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
0.6 | 5.4 | GO:0045019 | negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
0.6 | 1.8 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
0.6 | 3.0 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
0.6 | 3.0 | GO:0045542 | positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
0.6 | 1.8 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) |
0.6 | 2.4 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.6 | 1.2 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.6 | 2.4 | GO:0006534 | cysteine metabolic process(GO:0006534) |
0.6 | 1.2 | GO:0060336 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
0.6 | 0.6 | GO:0036258 | multivesicular body assembly(GO:0036258) |
0.6 | 0.6 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.6 | 1.1 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.6 | 3.4 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.6 | 2.3 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.6 | 0.6 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.6 | 1.7 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
0.6 | 1.1 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.6 | 1.7 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.6 | 2.2 | GO:0035356 | cellular triglyceride homeostasis(GO:0035356) |
0.6 | 7.7 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.6 | 0.6 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.6 | 2.2 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.5 | 0.5 | GO:0090160 | Golgi to lysosome transport(GO:0090160) |
0.5 | 1.6 | GO:0035973 | aggrephagy(GO:0035973) |
0.5 | 2.2 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
0.5 | 1.6 | GO:1990168 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
0.5 | 2.1 | GO:0055091 | phospholipid homeostasis(GO:0055091) |
0.5 | 3.2 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.5 | 4.8 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.5 | 1.6 | GO:0033131 | regulation of glucokinase activity(GO:0033131) |
0.5 | 5.8 | GO:0043248 | proteasome assembly(GO:0043248) |
0.5 | 2.6 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.5 | 1.1 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.5 | 0.5 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
0.5 | 1.6 | GO:0097360 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
0.5 | 2.6 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.5 | 1.5 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.5 | 2.6 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
0.5 | 1.5 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
0.5 | 1.5 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.5 | 10.3 | GO:0006301 | postreplication repair(GO:0006301) |
0.5 | 1.0 | GO:0060066 | oviduct development(GO:0060066) |
0.5 | 3.6 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
0.5 | 1.5 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.5 | 2.5 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.5 | 1.0 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.5 | 1.0 | GO:0010039 | response to iron ion(GO:0010039) |
0.5 | 0.5 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.5 | 3.0 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.5 | 5.5 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.5 | 1.0 | GO:0035425 | autocrine signaling(GO:0035425) |
0.5 | 1.5 | GO:0002584 | negative regulation of antigen processing and presentation of peptide antigen(GO:0002584) |
0.5 | 3.0 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.5 | 1.0 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.5 | 0.5 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.5 | 1.0 | GO:0009169 | ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.5 | 1.5 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.5 | 2.0 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.5 | 1.9 | GO:0045842 | positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
0.5 | 1.9 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.5 | 1.4 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.5 | 1.4 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.5 | 0.5 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.5 | 1.9 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
0.5 | 7.1 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.5 | 1.4 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.5 | 2.4 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.5 | 1.4 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.5 | 0.5 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
0.5 | 2.8 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.5 | 1.4 | GO:0006570 | tyrosine metabolic process(GO:0006570) |
0.5 | 0.9 | GO:0002215 | defense response to nematode(GO:0002215) |
0.5 | 3.7 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
0.5 | 0.5 | GO:0045908 | negative regulation of vasodilation(GO:0045908) |
0.5 | 4.1 | GO:0006388 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.5 | 1.4 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.5 | 1.4 | GO:0090031 | positive regulation of steroid hormone biosynthetic process(GO:0090031) |
0.5 | 0.9 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.5 | 2.7 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.5 | 9.5 | GO:0030195 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
0.5 | 0.9 | GO:0003331 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
0.5 | 4.1 | GO:0021702 | cerebellar Purkinje cell differentiation(GO:0021702) |
0.4 | 0.9 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
0.4 | 3.1 | GO:0034162 | toll-like receptor 9 signaling pathway(GO:0034162) |
0.4 | 1.3 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
0.4 | 1.8 | GO:0060335 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.4 | 0.9 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
0.4 | 1.3 | GO:1904684 | regulation of metalloendopeptidase activity(GO:1904683) negative regulation of metalloendopeptidase activity(GO:1904684) negative regulation of metallopeptidase activity(GO:1905049) |
0.4 | 0.9 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.4 | 1.3 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.4 | 0.9 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
0.4 | 1.3 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.4 | 1.7 | GO:0072282 | metanephric nephron tubule morphogenesis(GO:0072282) |
0.4 | 2.6 | GO:1902414 | protein localization to cell junction(GO:1902414) |
0.4 | 1.3 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
0.4 | 0.9 | GO:0042984 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.4 | 1.3 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.4 | 5.2 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.4 | 1.3 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.4 | 1.3 | GO:0030242 | pexophagy(GO:0030242) |
0.4 | 3.0 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.4 | 1.7 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.4 | 1.3 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
0.4 | 5.6 | GO:0031297 | replication fork processing(GO:0031297) |
0.4 | 0.4 | GO:0071072 | negative regulation of phospholipid biosynthetic process(GO:0071072) |
0.4 | 0.9 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
0.4 | 3.4 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.4 | 2.5 | GO:0035437 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.4 | 1.3 | GO:0072610 | interleukin-12 secretion(GO:0072610) regulation of interleukin-12 secretion(GO:2001182) |
0.4 | 1.3 | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
0.4 | 8.4 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
0.4 | 1.7 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.4 | 2.1 | GO:0036315 | cellular response to sterol(GO:0036315) |
0.4 | 2.5 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.4 | 1.3 | GO:0070836 | caveola assembly(GO:0070836) |
0.4 | 0.8 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.4 | 2.5 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
0.4 | 5.0 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.4 | 0.8 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.4 | 1.2 | GO:1900193 | regulation of oocyte maturation(GO:1900193) |
0.4 | 1.6 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
0.4 | 5.8 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
0.4 | 1.6 | GO:0010990 | regulation of SMAD protein complex assembly(GO:0010990) |
0.4 | 1.6 | GO:0018211 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.4 | 9.4 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.4 | 0.4 | GO:0006817 | phosphate ion transport(GO:0006817) |
0.4 | 1.2 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.4 | 2.8 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
0.4 | 4.1 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.4 | 4.9 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.4 | 2.4 | GO:0015871 | choline transport(GO:0015871) |
0.4 | 1.2 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.4 | 2.8 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
0.4 | 0.8 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.4 | 0.8 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.4 | 1.2 | GO:0090240 | positive regulation of histone H4 acetylation(GO:0090240) |
0.4 | 0.8 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.4 | 0.8 | GO:0010912 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
0.4 | 0.8 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
0.4 | 0.8 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
0.4 | 2.0 | GO:0030913 | paranodal junction assembly(GO:0030913) |
0.4 | 1.2 | GO:0042427 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
0.4 | 1.6 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.4 | 1.2 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.4 | 0.4 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.4 | 11.4 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.4 | 1.6 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
0.4 | 1.9 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.4 | 0.8 | GO:0072179 | nephric duct formation(GO:0072179) |
0.4 | 1.2 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.4 | 0.8 | GO:0097343 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.4 | 1.5 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.4 | 1.2 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.4 | 0.8 | GO:2000667 | positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-13 secretion(GO:2000667) |
0.4 | 6.5 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.4 | 5.4 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.4 | 1.1 | GO:0009071 | serine family amino acid catabolic process(GO:0009071) |
0.4 | 1.1 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
0.4 | 1.5 | GO:0042795 | snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.4 | 1.9 | GO:0072674 | multinuclear osteoclast differentiation(GO:0072674) |
0.4 | 3.4 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.4 | 3.8 | GO:0045821 | positive regulation of glycolytic process(GO:0045821) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) |
0.4 | 1.9 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.4 | 1.1 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.4 | 0.4 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.4 | 8.2 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.4 | 1.9 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.4 | 1.9 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.4 | 0.7 | GO:1903423 | positive regulation of synaptic vesicle recycling(GO:1903423) |
0.4 | 3.3 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.4 | 0.4 | GO:0060268 | negative regulation of respiratory burst(GO:0060268) |
0.4 | 2.9 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.4 | 7.7 | GO:0050892 | intestinal absorption(GO:0050892) |
0.4 | 0.7 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.4 | 1.1 | GO:0006059 | hexitol metabolic process(GO:0006059) |
0.4 | 0.7 | GO:0002679 | respiratory burst involved in defense response(GO:0002679) |
0.4 | 0.4 | GO:0009078 | alanine metabolic process(GO:0006522) pyruvate family amino acid metabolic process(GO:0009078) |
0.4 | 1.1 | GO:0032252 | secretory granule localization(GO:0032252) |
0.4 | 0.7 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.4 | 1.1 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.4 | 2.5 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.4 | 0.4 | GO:0009595 | detection of biotic stimulus(GO:0009595) detection of bacterium(GO:0016045) detection of other organism(GO:0098543) detection of external biotic stimulus(GO:0098581) |
0.4 | 3.2 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
0.4 | 0.7 | GO:0032898 | neurotrophin production(GO:0032898) |
0.4 | 2.9 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
0.4 | 1.1 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.4 | 1.1 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.4 | 2.5 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.4 | 6.4 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.4 | 1.1 | GO:0019896 | axonal transport of mitochondrion(GO:0019896) |
0.4 | 0.7 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.4 | 1.4 | GO:0060023 | soft palate development(GO:0060023) |
0.4 | 1.1 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.4 | 2.8 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.4 | 0.7 | GO:0009437 | carnitine metabolic process(GO:0009437) |
0.4 | 0.4 | GO:2000977 | regulation of forebrain neuron differentiation(GO:2000977) |
0.4 | 1.8 | GO:0032471 | negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
0.4 | 2.5 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.4 | 0.4 | GO:0072309 | mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis(GO:0072309) |
0.3 | 1.7 | GO:1901299 | negative regulation of hydrogen peroxide-mediated programmed cell death(GO:1901299) |
0.3 | 0.7 | GO:0090324 | negative regulation of oxidative phosphorylation(GO:0090324) |
0.3 | 0.7 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
0.3 | 2.8 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.3 | 6.6 | GO:0052696 | flavonoid biosynthetic process(GO:0009813) flavonoid glucuronidation(GO:0052696) |
0.3 | 1.0 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.3 | 1.4 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.3 | 2.4 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.3 | 1.0 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.3 | 1.7 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.3 | 1.7 | GO:0009642 | response to light intensity(GO:0009642) |
0.3 | 0.3 | GO:1901725 | regulation of histone deacetylase activity(GO:1901725) |
0.3 | 1.4 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.3 | 2.1 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.3 | 0.7 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
0.3 | 1.0 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
0.3 | 1.0 | GO:2000774 | positive regulation of cell aging(GO:0090343) positive regulation of cellular senescence(GO:2000774) |
0.3 | 0.7 | GO:0070343 | white fat cell proliferation(GO:0070343) regulation of white fat cell proliferation(GO:0070350) |
0.3 | 1.0 | GO:0045896 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.3 | 3.1 | GO:0071357 | type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
0.3 | 10.2 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.3 | 0.7 | GO:0061535 | glutamate secretion, neurotransmission(GO:0061535) |
0.3 | 0.3 | GO:0000963 | mitochondrial RNA processing(GO:0000963) |
0.3 | 0.7 | GO:0051176 | positive regulation of sulfur metabolic process(GO:0051176) |
0.3 | 0.3 | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.3 | 0.3 | GO:0044800 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.3 | 1.7 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.3 | 0.7 | GO:0002838 | negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) |
0.3 | 1.0 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.3 | 1.7 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.3 | 3.3 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
0.3 | 0.3 | GO:0043134 | hindgut contraction(GO:0043133) regulation of hindgut contraction(GO:0043134) |
0.3 | 0.3 | GO:0048936 | peripheral nervous system neuron axonogenesis(GO:0048936) |
0.3 | 0.3 | GO:0002566 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.3 | 3.0 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.3 | 1.0 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.3 | 1.0 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
0.3 | 1.7 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.3 | 0.7 | GO:1902714 | negative regulation of interferon-gamma secretion(GO:1902714) |
0.3 | 0.7 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
0.3 | 2.0 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.3 | 0.7 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.3 | 0.7 | GO:0008595 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.3 | 1.0 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.3 | 4.9 | GO:0070266 | necroptotic process(GO:0070266) |
0.3 | 0.3 | GO:0055064 | chloride ion homeostasis(GO:0055064) |
0.3 | 0.7 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
0.3 | 0.7 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.3 | 0.3 | GO:0009452 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.3 | 1.0 | GO:0015888 | thiamine transport(GO:0015888) |
0.3 | 0.6 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
0.3 | 0.6 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.3 | 0.3 | GO:0042524 | negative regulation of tyrosine phosphorylation of Stat5 protein(GO:0042524) |
0.3 | 2.9 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.3 | 1.0 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.3 | 1.0 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.3 | 1.3 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.3 | 2.9 | GO:0070498 | interleukin-1-mediated signaling pathway(GO:0070498) |
0.3 | 1.3 | GO:1901679 | nucleotide transmembrane transport(GO:1901679) |
0.3 | 1.9 | GO:0019240 | citrulline biosynthetic process(GO:0019240) |
0.3 | 1.3 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.3 | 0.6 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
0.3 | 2.2 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.3 | 0.3 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
0.3 | 0.6 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.3 | 3.1 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.3 | 0.3 | GO:1903333 | negative regulation of protein folding(GO:1903333) |
0.3 | 1.9 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.3 | 0.3 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.3 | 10.3 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.3 | 0.9 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.3 | 1.6 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.3 | 2.8 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.3 | 1.2 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.3 | 2.2 | GO:1901339 | regulation of store-operated calcium channel activity(GO:1901339) |
0.3 | 0.9 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.3 | 0.3 | GO:0008050 | female courtship behavior(GO:0008050) |
0.3 | 1.2 | GO:0060613 | fat pad development(GO:0060613) |
0.3 | 0.9 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.3 | 1.2 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.3 | 0.6 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.3 | 0.6 | GO:0033499 | galactose catabolic process via UDP-galactose(GO:0033499) glycolytic process from galactose(GO:0061623) |
0.3 | 6.0 | GO:0006491 | N-glycan processing(GO:0006491) |
0.3 | 0.9 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.3 | 2.1 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.3 | 3.8 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.3 | 0.9 | GO:0061624 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
0.3 | 2.1 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
0.3 | 0.9 | GO:0009838 | abscission(GO:0009838) |
0.3 | 3.8 | GO:1900153 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
0.3 | 0.6 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.3 | 0.9 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.3 | 0.6 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.3 | 1.4 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.3 | 0.3 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.3 | 1.4 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.3 | 1.7 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.3 | 0.6 | GO:0035627 | ceramide transport(GO:0035627) |
0.3 | 2.6 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.3 | 1.1 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.3 | 0.3 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.3 | 2.6 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
0.3 | 0.6 | GO:0019042 | viral latency(GO:0019042) |
0.3 | 0.3 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.3 | 1.1 | GO:0032608 | interferon-beta production(GO:0032608) |
0.3 | 0.8 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.3 | 7.6 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.3 | 5.4 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.3 | 1.4 | GO:0001842 | neural fold formation(GO:0001842) |
0.3 | 1.1 | GO:0034312 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
0.3 | 0.8 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
0.3 | 0.8 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.3 | 5.3 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.3 | 2.2 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.3 | 0.6 | GO:0021564 | vagus nerve development(GO:0021564) |
0.3 | 1.4 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.3 | 0.8 | GO:0030638 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.3 | 2.2 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.3 | 0.3 | GO:0061450 | trophoblast cell migration(GO:0061450) |
0.3 | 0.3 | GO:1901620 | regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901620) |
0.3 | 1.1 | GO:0001705 | ectoderm formation(GO:0001705) |
0.3 | 3.0 | GO:0090207 | regulation of triglyceride metabolic process(GO:0090207) |
0.3 | 2.7 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
0.3 | 2.5 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.3 | 6.0 | GO:0048240 | sperm capacitation(GO:0048240) |
0.3 | 1.6 | GO:0015671 | oxygen transport(GO:0015671) |
0.3 | 1.1 | GO:0006415 | translational termination(GO:0006415) |
0.3 | 1.1 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.3 | 2.5 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
0.3 | 0.5 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
0.3 | 1.1 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.3 | 1.6 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.3 | 1.1 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
0.3 | 0.3 | GO:1903596 | regulation of gap junction assembly(GO:1903596) positive regulation of gap junction assembly(GO:1903598) |
0.3 | 1.9 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.3 | 0.8 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.3 | 4.1 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.3 | 6.5 | GO:0006778 | porphyrin-containing compound metabolic process(GO:0006778) |
0.3 | 0.5 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.3 | 2.1 | GO:0070269 | pyroptosis(GO:0070269) |
0.3 | 1.9 | GO:0000338 | protein deneddylation(GO:0000338) cullin deneddylation(GO:0010388) |
0.3 | 0.8 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.3 | 0.5 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.3 | 0.5 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
0.3 | 2.7 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.3 | 2.4 | GO:0090129 | positive regulation of synapse maturation(GO:0090129) |
0.3 | 0.3 | GO:0061092 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
0.3 | 1.3 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.3 | 1.6 | GO:0006706 | steroid catabolic process(GO:0006706) |
0.3 | 2.4 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.3 | 2.1 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.3 | 3.7 | GO:0006828 | manganese ion transport(GO:0006828) |
0.3 | 0.5 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.3 | 3.9 | GO:0017144 | drug metabolic process(GO:0017144) |
0.3 | 0.3 | GO:0032753 | positive regulation of interleukin-4 production(GO:0032753) |
0.3 | 2.1 | GO:0070328 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.3 | 0.5 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.3 | 0.5 | GO:0036498 | IRE1-mediated unfolded protein response(GO:0036498) |
0.3 | 0.8 | GO:0007343 | egg activation(GO:0007343) |
0.3 | 3.9 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.3 | 0.8 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.3 | 2.3 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.3 | 2.3 | GO:0030049 | muscle filament sliding(GO:0030049) |
0.3 | 0.3 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.3 | 0.3 | GO:0030908 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.3 | 1.0 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.3 | 12.4 | GO:0046488 | phosphatidylinositol metabolic process(GO:0046488) |
0.3 | 0.5 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.3 | 0.3 | GO:0018904 | ether metabolic process(GO:0018904) |
0.3 | 1.0 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.3 | 0.3 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
0.3 | 2.8 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.3 | 0.3 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
0.3 | 2.0 | GO:1901663 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.3 | 0.3 | GO:0048296 | isotype switching to IgA isotypes(GO:0048290) regulation of isotype switching to IgA isotypes(GO:0048296) |
0.3 | 2.8 | GO:0006721 | terpenoid metabolic process(GO:0006721) |
0.3 | 3.6 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.3 | 1.3 | GO:0047497 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.3 | 0.5 | GO:0006266 | DNA ligation(GO:0006266) DNA ligation involved in DNA repair(GO:0051103) |
0.3 | 1.0 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.3 | 0.8 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.3 | 1.5 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.3 | 0.5 | GO:0042938 | dipeptide transport(GO:0042938) |
0.3 | 1.8 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.3 | 0.5 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
0.3 | 0.5 | GO:0070561 | vitamin D receptor signaling pathway(GO:0070561) |
0.2 | 1.5 | GO:0048537 | mucosal-associated lymphoid tissue development(GO:0048537) Peyer's patch development(GO:0048541) |
0.2 | 0.7 | GO:2001270 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) |
0.2 | 12.4 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.2 | 0.7 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.2 | 0.7 | GO:0016139 | glycoside metabolic process(GO:0016137) glycoside catabolic process(GO:0016139) |
0.2 | 1.5 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.2 | 0.5 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) detection of bacterial lipopeptide(GO:0070340) |
0.2 | 1.0 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.2 | 0.7 | GO:0032788 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.2 | 4.2 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.2 | 0.5 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.2 | 0.2 | GO:0070384 | Harderian gland development(GO:0070384) |
0.2 | 0.7 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
0.2 | 1.0 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.2 | 1.4 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
0.2 | 0.7 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.2 | 0.7 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.2 | 1.0 | GO:0060631 | regulation of meiosis I(GO:0060631) |
0.2 | 0.2 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
0.2 | 4.3 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.2 | 1.2 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.2 | 1.2 | GO:0009446 | putrescine biosynthetic process(GO:0009446) |
0.2 | 0.7 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
0.2 | 0.5 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
0.2 | 6.2 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
0.2 | 1.4 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.2 | 2.4 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.2 | 0.5 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.2 | 1.2 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.2 | 1.0 | GO:0015791 | polyol transport(GO:0015791) |
0.2 | 0.2 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.2 | 0.2 | GO:1902306 | negative regulation of sodium ion transmembrane transport(GO:1902306) |
0.2 | 0.5 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.2 | 0.2 | GO:0010749 | regulation of nitric oxide mediated signal transduction(GO:0010749) |
0.2 | 1.4 | GO:0060900 | embryonic camera-type eye formation(GO:0060900) |
0.2 | 1.2 | GO:0045631 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.2 | 0.7 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.2 | 0.2 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
0.2 | 1.6 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.2 | 0.9 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.2 | 0.2 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.2 | 3.2 | GO:0014850 | response to muscle activity(GO:0014850) |
0.2 | 0.9 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.2 | 1.2 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.2 | 0.9 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.2 | 1.1 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
0.2 | 0.9 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.2 | 0.5 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
0.2 | 1.1 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
0.2 | 1.8 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.2 | 0.7 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.2 | 1.4 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.2 | 1.1 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.2 | 0.5 | GO:0060231 | mesenchymal to epithelial transition(GO:0060231) |
0.2 | 0.2 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
0.2 | 0.9 | GO:0043097 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.2 | 2.9 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.2 | 0.5 | GO:0001555 | oocyte growth(GO:0001555) |
0.2 | 0.9 | GO:1901978 | positive regulation of cell cycle checkpoint(GO:1901978) |
0.2 | 0.5 | GO:1904861 | excitatory synapse assembly(GO:1904861) |
0.2 | 0.4 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
0.2 | 0.9 | GO:0033260 | nuclear DNA replication(GO:0033260) |
0.2 | 0.9 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.2 | 1.6 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.2 | 10.3 | GO:0009062 | fatty acid catabolic process(GO:0009062) |
0.2 | 0.7 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.2 | 0.4 | GO:1902969 | mitotic DNA replication(GO:1902969) |
0.2 | 0.2 | GO:0003340 | negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003340) |
0.2 | 2.9 | GO:0051904 | pigment granule transport(GO:0051904) |
0.2 | 0.2 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.2 | 0.7 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.2 | 2.4 | GO:0007602 | phototransduction(GO:0007602) |
0.2 | 2.6 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
0.2 | 0.4 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.2 | 0.4 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.2 | 0.7 | GO:0019086 | late viral transcription(GO:0019086) |
0.2 | 2.0 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.2 | 1.1 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.2 | 5.0 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.2 | 5.7 | GO:1902850 | mitotic spindle assembly(GO:0090307) microtubule cytoskeleton organization involved in mitosis(GO:1902850) |
0.2 | 0.7 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
0.2 | 0.7 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
0.2 | 0.4 | GO:0071501 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.2 | 0.4 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.2 | 1.1 | GO:0002084 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.2 | 1.1 | GO:0051026 | chiasma assembly(GO:0051026) |
0.2 | 2.6 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.2 | 1.3 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.2 | 0.4 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.2 | 0.4 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.2 | 0.2 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
0.2 | 1.9 | GO:1902042 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
0.2 | 0.4 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.2 | 1.3 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.2 | 0.4 | GO:0048023 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.2 | 0.6 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.2 | 0.6 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.2 | 29.5 | GO:0010466 | negative regulation of peptidase activity(GO:0010466) |
0.2 | 0.6 | GO:0009650 | UV protection(GO:0009650) |
0.2 | 0.6 | GO:0009629 | response to gravity(GO:0009629) |
0.2 | 0.6 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.2 | 1.1 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.2 | 0.4 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.2 | 0.6 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.2 | 0.6 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
0.2 | 0.8 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
0.2 | 1.3 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.2 | 1.0 | GO:0031442 | positive regulation of mRNA 3'-end processing(GO:0031442) |
0.2 | 0.4 | GO:0002432 | granuloma formation(GO:0002432) |
0.2 | 3.1 | GO:0035058 | nonmotile primary cilium assembly(GO:0035058) |
0.2 | 0.8 | GO:0014022 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
0.2 | 0.4 | GO:0015809 | arginine transport(GO:0015809) |
0.2 | 4.6 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.2 | 0.8 | GO:0050994 | regulation of lipid catabolic process(GO:0050994) |
0.2 | 0.2 | GO:0051299 | regulation of mitotic centrosome separation(GO:0046602) centrosome separation(GO:0051299) |
0.2 | 0.4 | GO:0006720 | isoprenoid metabolic process(GO:0006720) |
0.2 | 0.4 | GO:0060285 | cilium or flagellum-dependent cell motility(GO:0001539) cilium-dependent cell motility(GO:0060285) |
0.2 | 0.2 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
0.2 | 2.5 | GO:0032785 | negative regulation of DNA-templated transcription, elongation(GO:0032785) |
0.2 | 1.0 | GO:0008210 | estrogen metabolic process(GO:0008210) |
0.2 | 1.2 | GO:0070828 | heterochromatin organization(GO:0070828) |
0.2 | 0.6 | GO:0009201 | ribonucleoside triphosphate biosynthetic process(GO:0009201) |
0.2 | 4.9 | GO:0009225 | nucleotide-sugar metabolic process(GO:0009225) |
0.2 | 0.8 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.2 | 1.0 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.2 | 0.6 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.2 | 0.6 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.2 | 4.7 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.2 | 0.6 | GO:0045075 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.2 | 0.8 | GO:0006692 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.2 | 1.0 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.2 | 0.4 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.2 | 0.4 | GO:0033058 | directional locomotion(GO:0033058) |
0.2 | 0.4 | GO:0009177 | deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) pyrimidine deoxyribonucleoside monophosphate biosynthetic process(GO:0009177) |
0.2 | 0.4 | GO:0002892 | type IIa hypersensitivity(GO:0001794) regulation of type IIa hypersensitivity(GO:0001796) positive regulation of type IIa hypersensitivity(GO:0001798) type II hypersensitivity(GO:0002445) regulation of type II hypersensitivity(GO:0002892) positive regulation of type II hypersensitivity(GO:0002894) |
0.2 | 2.4 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.2 | 0.6 | GO:0051451 | myoblast migration(GO:0051451) |
0.2 | 0.2 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.2 | 0.6 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.2 | 1.2 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.2 | 0.6 | GO:1900147 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
0.2 | 0.6 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
0.2 | 0.4 | GO:0021578 | hindbrain maturation(GO:0021578) central nervous system maturation(GO:0021626) |
0.2 | 5.1 | GO:0019319 | hexose biosynthetic process(GO:0019319) |
0.2 | 0.4 | GO:0051138 | regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
0.2 | 0.2 | GO:0061314 | Notch signaling involved in heart development(GO:0061314) |
0.2 | 2.0 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.2 | 2.0 | GO:0044406 | adhesion of symbiont to host(GO:0044406) |
0.2 | 0.8 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.2 | 0.4 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.2 | 0.8 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
0.2 | 0.2 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.2 | 0.2 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.2 | 1.0 | GO:0071168 | protein localization to chromatin(GO:0071168) |
0.2 | 7.2 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.2 | 0.6 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.2 | 0.8 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.2 | 0.2 | GO:0051905 | establishment of pigment granule localization(GO:0051905) |
0.2 | 0.6 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.2 | 0.6 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.2 | 0.6 | GO:0000730 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.2 | 1.0 | GO:0060676 | ureteric bud formation(GO:0060676) |
0.2 | 0.4 | GO:0033567 | DNA replication, Okazaki fragment processing(GO:0033567) DNA replication, removal of RNA primer(GO:0043137) |
0.2 | 0.2 | GO:0030070 | insulin processing(GO:0030070) |
0.2 | 0.4 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.2 | 1.7 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.2 | 0.8 | GO:0045836 | positive regulation of meiotic nuclear division(GO:0045836) |
0.2 | 0.4 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.2 | 0.6 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.2 | 2.6 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.2 | 0.2 | GO:0043309 | regulation of eosinophil degranulation(GO:0043309) |
0.2 | 0.8 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.2 | 0.8 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.2 | 0.4 | GO:0046184 | aldehyde biosynthetic process(GO:0046184) |
0.2 | 11.9 | GO:0051028 | mRNA transport(GO:0051028) |
0.2 | 0.2 | GO:0071727 | response to bacterial lipoprotein(GO:0032493) response to bacterial lipopeptide(GO:0070339) cellular response to bacterial lipoprotein(GO:0071220) cellular response to bacterial lipopeptide(GO:0071221) response to diacyl bacterial lipopeptide(GO:0071724) response to triacyl bacterial lipopeptide(GO:0071725) cellular response to diacyl bacterial lipopeptide(GO:0071726) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
0.2 | 0.2 | GO:2000104 | negative regulation of DNA-dependent DNA replication(GO:2000104) |
0.2 | 0.6 | GO:0002525 | acute inflammatory response to non-antigenic stimulus(GO:0002525) |
0.2 | 0.7 | GO:0034551 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.2 | 0.4 | GO:0061615 | glycolytic process through fructose-6-phosphate(GO:0061615) |
0.2 | 0.9 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.2 | 1.5 | GO:0006560 | proline metabolic process(GO:0006560) |
0.2 | 1.1 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.2 | 1.1 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
0.2 | 0.2 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.2 | 0.5 | GO:0009146 | purine nucleoside triphosphate catabolic process(GO:0009146) |
0.2 | 2.7 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
0.2 | 1.8 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
0.2 | 1.5 | GO:2000463 | positive regulation of excitatory postsynaptic potential(GO:2000463) |
0.2 | 1.8 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.2 | 2.7 | GO:0051298 | centrosome duplication(GO:0051298) |
0.2 | 0.5 | GO:0006655 | phosphatidylglycerol biosynthetic process(GO:0006655) |
0.2 | 0.5 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.2 | 0.2 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.2 | 0.2 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.2 | 0.5 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.2 | 0.4 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.2 | 0.5 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.2 | 0.5 | GO:1902775 | mitochondrial ribosome assembly(GO:0061668) mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.2 | 0.2 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.2 | 1.1 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.2 | 0.2 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.2 | 0.4 | GO:0061197 | fungiform papilla morphogenesis(GO:0061197) fungiform papilla formation(GO:0061198) |
0.2 | 0.7 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.2 | 0.2 | GO:0002669 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.2 | 0.4 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
0.2 | 0.7 | GO:0031055 | chromatin remodeling at centromere(GO:0031055) CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.2 | 1.1 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.2 | 0.5 | GO:0060242 | contact inhibition(GO:0060242) |
0.2 | 0.2 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.2 | 0.5 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.2 | 0.9 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.2 | 0.4 | GO:1902166 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
0.2 | 1.4 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
0.2 | 0.2 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.2 | 0.5 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.2 | 0.5 | GO:0009438 | methylglyoxal metabolic process(GO:0009438) |
0.2 | 0.7 | GO:0090188 | regulation of pancreatic juice secretion(GO:0090186) negative regulation of pancreatic juice secretion(GO:0090188) |
0.2 | 0.3 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.2 | 1.0 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.2 | 0.5 | GO:0032026 | response to magnesium ion(GO:0032026) |
0.2 | 0.7 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.2 | 1.0 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.2 | 3.1 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
0.2 | 1.2 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.2 | 0.5 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.2 | 0.9 | GO:0010818 | T cell chemotaxis(GO:0010818) |
0.2 | 0.5 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.2 | 0.5 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.2 | 0.2 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.2 | 10.7 | GO:0008033 | tRNA processing(GO:0008033) |
0.2 | 7.0 | GO:0006633 | fatty acid biosynthetic process(GO:0006633) |
0.2 | 2.7 | GO:1902017 | regulation of cilium assembly(GO:1902017) |
0.2 | 0.7 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.2 | 0.7 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.2 | 0.8 | GO:1903318 | negative regulation of protein processing(GO:0010955) negative regulation of protein maturation(GO:1903318) |
0.2 | 0.3 | GO:0015860 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
0.2 | 0.2 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.2 | 0.3 | GO:1900084 | regulation of peptidyl-tyrosine autophosphorylation(GO:1900084) |
0.2 | 0.2 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.2 | 0.2 | GO:0051956 | negative regulation of amino acid transport(GO:0051956) |
0.2 | 0.3 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.2 | 2.3 | GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
0.2 | 1.0 | GO:0043649 | dicarboxylic acid catabolic process(GO:0043649) |
0.2 | 0.2 | GO:0051004 | regulation of lipoprotein lipase activity(GO:0051004) |
0.2 | 0.3 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
0.2 | 0.5 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.2 | 3.8 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
0.2 | 0.2 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
0.2 | 0.3 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
0.2 | 0.5 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.2 | 0.7 | GO:0045006 | DNA deamination(GO:0045006) |
0.2 | 1.1 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.2 | 0.5 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.2 | 0.2 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.2 | 1.0 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.2 | 0.2 | GO:0009624 | response to nematode(GO:0009624) |
0.2 | 0.2 | GO:0042891 | antibiotic transport(GO:0042891) |
0.2 | 1.3 | GO:0035967 | cellular response to topologically incorrect protein(GO:0035967) |
0.2 | 0.8 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.2 | 0.5 | GO:0000492 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.2 | 1.0 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.2 | 0.2 | GO:0071071 | regulation of phospholipid biosynthetic process(GO:0071071) |
0.2 | 0.2 | GO:0046628 | positive regulation of insulin receptor signaling pathway(GO:0046628) |
0.2 | 0.2 | GO:1990441 | negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990441) |
0.2 | 1.5 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.2 | 0.3 | GO:0033762 | response to glucagon(GO:0033762) |
0.2 | 0.3 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.2 | 0.5 | GO:0008054 | negative regulation of cyclin-dependent protein serine/threonine kinase by cyclin degradation(GO:0008054) |
0.2 | 0.5 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.2 | 0.6 | GO:2000780 | negative regulation of DNA repair(GO:0045738) negative regulation of double-strand break repair(GO:2000780) |
0.2 | 1.9 | GO:0045116 | protein neddylation(GO:0045116) |
0.2 | 1.1 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.2 | 0.5 | GO:0043144 | snoRNA processing(GO:0043144) |
0.2 | 1.1 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.2 | 0.5 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
0.2 | 0.5 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.2 | 0.2 | GO:0046337 | phosphatidylethanolamine metabolic process(GO:0046337) |
0.2 | 0.8 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.2 | 1.4 | GO:0043206 | extracellular fibril organization(GO:0043206) fibril organization(GO:0097435) |
0.2 | 0.2 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.2 | 0.6 | GO:0051306 | mitotic sister chromatid separation(GO:0051306) |
0.2 | 0.2 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
0.2 | 3.1 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.2 | 0.8 | GO:0051013 | microtubule severing(GO:0051013) |
0.2 | 0.2 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.2 | 0.9 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.2 | 0.8 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.2 | 0.2 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.2 | 0.2 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.2 | 0.3 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.2 | 0.3 | GO:1901662 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.2 | 0.5 | GO:0044381 | glucose import in response to insulin stimulus(GO:0044381) regulation of glucose import in response to insulin stimulus(GO:2001273) |
0.2 | 1.2 | GO:1901796 | regulation of signal transduction by p53 class mediator(GO:1901796) |
0.2 | 0.8 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
0.2 | 0.3 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
0.2 | 0.3 | GO:0006868 | glutamine transport(GO:0006868) |
0.2 | 1.8 | GO:0006879 | cellular iron ion homeostasis(GO:0006879) |
0.2 | 0.6 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.2 | 0.2 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.2 | 0.2 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.2 | 1.5 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.2 | 0.3 | GO:0046700 | heterocycle catabolic process(GO:0046700) |
0.2 | 1.1 | GO:0051014 | actin filament severing(GO:0051014) |
0.2 | 4.1 | GO:0007585 | respiratory gaseous exchange(GO:0007585) |
0.2 | 0.5 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.2 | 0.6 | GO:0032736 | positive regulation of interleukin-13 production(GO:0032736) |
0.2 | 0.6 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.1 | 0.1 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
0.1 | 1.3 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
0.1 | 1.0 | GO:0007379 | segment specification(GO:0007379) |
0.1 | 0.4 | GO:0034340 | response to type I interferon(GO:0034340) |
0.1 | 0.3 | GO:0038202 | TORC1 signaling(GO:0038202) regulation of TORC1 signaling(GO:1903432) |
0.1 | 0.7 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.1 | 1.0 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
0.1 | 0.3 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.1 | 1.0 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.1 | 0.1 | GO:0060561 | apoptotic process involved in morphogenesis(GO:0060561) |
0.1 | 0.1 | GO:0019530 | taurine metabolic process(GO:0019530) |
0.1 | 0.3 | GO:0021692 | cerebellar Purkinje cell layer morphogenesis(GO:0021692) |
0.1 | 0.3 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.1 | 1.0 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.1 | 0.7 | GO:0046325 | negative regulation of glucose import(GO:0046325) |
0.1 | 0.6 | GO:0046641 | positive regulation of alpha-beta T cell proliferation(GO:0046641) |
0.1 | 0.6 | GO:1901533 | negative regulation of hematopoietic progenitor cell differentiation(GO:1901533) |
0.1 | 1.7 | GO:1901998 | toxin transport(GO:1901998) |
0.1 | 2.0 | GO:0016574 | histone ubiquitination(GO:0016574) |
0.1 | 0.1 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.1 | 0.3 | GO:2000836 | androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
0.1 | 1.2 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.1 | 0.4 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.1 | 1.4 | GO:0008206 | bile acid metabolic process(GO:0008206) |
0.1 | 0.4 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.1 | 0.1 | GO:0034501 | protein localization to kinetochore(GO:0034501) protein localization to chromosome, centromeric region(GO:0071459) |
0.1 | 3.5 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.1 | 0.1 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
0.1 | 0.4 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) positive regulation of mast cell chemotaxis(GO:0060754) |
0.1 | 0.3 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.1 | 0.1 | GO:0060167 | regulation of adenosine receptor signaling pathway(GO:0060167) |
0.1 | 0.3 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.1 | 0.6 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.1 | 0.6 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.1 | 0.4 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.1 | 0.7 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.1 | 0.3 | GO:2000510 | positive regulation of dendritic cell chemotaxis(GO:2000510) |
0.1 | 4.4 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.1 | 0.3 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.1 | 0.6 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
0.1 | 0.3 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.1 | 0.6 | GO:0065005 | protein-lipid complex assembly(GO:0065005) |
0.1 | 0.3 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.1 | 0.4 | GO:0043545 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.1 | 0.1 | GO:1901740 | negative regulation of myoblast fusion(GO:1901740) |
0.1 | 0.4 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.1 | 0.1 | GO:0009310 | amine catabolic process(GO:0009310) |
0.1 | 0.3 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.1 | 2.9 | GO:0033003 | regulation of mast cell activation(GO:0033003) |
0.1 | 0.1 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.1 | 0.3 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.1 | 0.4 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.1 | 0.5 | GO:0033599 | regulation of mammary gland epithelial cell proliferation(GO:0033599) |
0.1 | 0.1 | GO:0010958 | regulation of amino acid import(GO:0010958) |
0.1 | 0.3 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.1 | 0.1 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.1 | 0.5 | GO:2000288 | positive regulation of myoblast proliferation(GO:2000288) |
0.1 | 0.3 | GO:0051799 | negative regulation of hair follicle development(GO:0051799) |
0.1 | 0.9 | GO:0002347 | response to tumor cell(GO:0002347) |
0.1 | 0.9 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
0.1 | 0.4 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.1 | 0.3 | GO:0035962 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.1 | 0.1 | GO:0009215 | purine deoxyribonucleoside triphosphate metabolic process(GO:0009215) |
0.1 | 0.3 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.1 | 0.1 | GO:2000409 | T cell extravasation(GO:0072683) regulation of T cell extravasation(GO:2000407) positive regulation of T cell extravasation(GO:2000409) |
0.1 | 0.5 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.1 | 1.0 | GO:0000154 | rRNA modification(GO:0000154) |
0.1 | 0.1 | GO:0052472 | modulation by host of viral transcription(GO:0043921) modulation of transcription in other organism involved in symbiotic interaction(GO:0052312) modulation by host of symbiont transcription(GO:0052472) |
0.1 | 0.6 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.1 | 0.1 | GO:0046348 | N-acetylneuraminate catabolic process(GO:0019262) amino sugar catabolic process(GO:0046348) |
0.1 | 1.0 | GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) |
0.1 | 0.4 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.1 | 0.3 | GO:0002551 | mast cell chemotaxis(GO:0002551) |
0.1 | 0.3 | GO:0030576 | Cajal body organization(GO:0030576) |
0.1 | 1.7 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.1 | 0.5 | GO:0034398 | telomere tethering at nuclear periphery(GO:0034398) meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.1 | 0.8 | GO:0046470 | phosphatidylcholine metabolic process(GO:0046470) |
0.1 | 0.6 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.1 | 0.1 | GO:0014045 | establishment of endothelial blood-brain barrier(GO:0014045) |
0.1 | 0.3 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.1 | 0.4 | GO:0043416 | regulation of skeletal muscle tissue regeneration(GO:0043416) |
0.1 | 0.3 | GO:1901976 | regulation of cell cycle checkpoint(GO:1901976) |
0.1 | 0.5 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) |
0.1 | 0.1 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.1 | 0.6 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
0.1 | 0.3 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.1 | 0.4 | GO:0014072 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.1 | 0.2 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.1 | 0.6 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
0.1 | 0.5 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.1 | 0.1 | GO:0046013 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
0.1 | 0.1 | GO:0090148 | membrane fission(GO:0090148) |
0.1 | 0.1 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.1 | 0.9 | GO:0042635 | positive regulation of hair cycle(GO:0042635) positive regulation of hair follicle development(GO:0051798) |
0.1 | 2.5 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.1 | 2.3 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
0.1 | 0.1 | GO:2000195 | negative regulation of female gonad development(GO:2000195) |
0.1 | 0.4 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
0.1 | 0.6 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.1 | 0.8 | GO:0048535 | lymph node development(GO:0048535) |
0.1 | 0.6 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.1 | 7.2 | GO:0016042 | lipid catabolic process(GO:0016042) |
0.1 | 1.1 | GO:0042745 | circadian sleep/wake cycle(GO:0042745) |
0.1 | 0.2 | GO:0042435 | indole-containing compound biosynthetic process(GO:0042435) |
0.1 | 0.1 | GO:0045625 | regulation of T-helper 1 cell differentiation(GO:0045625) |
0.1 | 0.6 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.1 | 1.0 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) glucosamine-containing compound metabolic process(GO:1901071) |
0.1 | 0.5 | GO:0071415 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
0.1 | 0.5 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.1 | 0.4 | GO:0010543 | regulation of platelet activation(GO:0010543) |
0.1 | 0.2 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
0.1 | 0.5 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.1 | 0.6 | GO:0001845 | phagolysosome assembly(GO:0001845) |
0.1 | 0.1 | GO:0033087 | negative regulation of immature T cell proliferation(GO:0033087) |
0.1 | 1.3 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.1 | 8.9 | GO:0006457 | protein folding(GO:0006457) |
0.1 | 0.9 | GO:0016575 | histone deacetylation(GO:0016575) |
0.1 | 0.6 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.1 | 0.8 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.1 | 0.5 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.1 | 1.4 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.1 | 0.5 | GO:0000012 | single strand break repair(GO:0000012) |
0.1 | 0.5 | GO:0035864 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.1 | 0.3 | GO:0023035 | CD40 signaling pathway(GO:0023035) |
0.1 | 0.6 | GO:0042044 | fluid transport(GO:0042044) |
0.1 | 0.8 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.1 | 0.2 | GO:0007529 | establishment of synaptic specificity at neuromuscular junction(GO:0007529) |
0.1 | 0.1 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.1 | 0.2 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.1 | 0.5 | GO:1900424 | regulation of defense response to bacterium(GO:1900424) |
0.1 | 1.2 | GO:0002437 | inflammatory response to antigenic stimulus(GO:0002437) |
0.1 | 0.3 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.1 | 2.4 | GO:0090662 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.1 | 0.4 | GO:0045078 | positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
0.1 | 0.3 | GO:0002381 | immunoglobulin production involved in immunoglobulin mediated immune response(GO:0002381) |
0.1 | 0.1 | GO:0031049 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.1 | 0.3 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.1 | 0.3 | GO:0072161 | mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.1 | 0.6 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.1 | 0.3 | GO:0031116 | positive regulation of microtubule polymerization(GO:0031116) |
0.1 | 0.2 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.1 | 0.1 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.1 | 0.2 | GO:0046087 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.1 | 0.1 | GO:0048478 | replication fork protection(GO:0048478) |
0.1 | 2.1 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.1 | 0.3 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.1 | 0.5 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.1 | 0.3 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.1 | 0.1 | GO:0016125 | sterol metabolic process(GO:0016125) |
0.1 | 2.6 | GO:0006956 | complement activation(GO:0006956) |
0.1 | 0.2 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
0.1 | 0.3 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.1 | 1.0 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.1 | 0.2 | GO:0090005 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
0.1 | 1.2 | GO:0035825 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.1 | 0.1 | GO:0035740 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) |
0.1 | 0.5 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.1 | 0.2 | GO:0014056 | acetylcholine secretion, neurotransmission(GO:0014055) regulation of acetylcholine secretion, neurotransmission(GO:0014056) |
0.1 | 2.5 | GO:0006694 | steroid biosynthetic process(GO:0006694) |
0.1 | 0.3 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.1 | 1.0 | GO:0045839 | negative regulation of mitotic nuclear division(GO:0045839) |
0.1 | 0.1 | GO:0097283 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
0.1 | 1.6 | GO:0034644 | cellular response to UV(GO:0034644) |
0.1 | 0.1 | GO:0007228 | positive regulation of hh target transcription factor activity(GO:0007228) |
0.1 | 0.1 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
0.1 | 0.1 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.1 | 0.8 | GO:0003301 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.1 | 0.2 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.1 | 2.7 | GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
0.1 | 0.8 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.1 | 0.1 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
0.1 | 0.5 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.1 | 0.1 | GO:0006563 | L-serine metabolic process(GO:0006563) |
0.1 | 0.6 | GO:0043967 | histone H4 acetylation(GO:0043967) |
0.1 | 0.7 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.1 | 0.6 | GO:0007549 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.1 | 1.0 | GO:0061436 | regulation of water loss via skin(GO:0033561) establishment of skin barrier(GO:0061436) |
0.1 | 0.6 | GO:0070234 | positive regulation of T cell apoptotic process(GO:0070234) |
0.1 | 0.3 | GO:1900101 | regulation of endoplasmic reticulum unfolded protein response(GO:1900101) |
0.1 | 0.3 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
0.1 | 0.3 | GO:0042517 | positive regulation of tyrosine phosphorylation of Stat3 protein(GO:0042517) |
0.1 | 0.1 | GO:0032042 | mitochondrial DNA metabolic process(GO:0032042) |
0.1 | 0.1 | GO:1901201 | regulation of extracellular matrix assembly(GO:1901201) |
0.1 | 0.1 | GO:0002246 | wound healing involved in inflammatory response(GO:0002246) inflammatory response to wounding(GO:0090594) |
0.1 | 0.2 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) inner cell mass cellular morphogenesis(GO:0001828) |
0.1 | 0.1 | GO:0032490 | detection of molecule of bacterial origin(GO:0032490) |
0.1 | 2.5 | GO:0009267 | cellular response to starvation(GO:0009267) |
0.1 | 0.1 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.1 | 0.2 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.1 | 0.2 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.1 | 0.1 | GO:0033559 | unsaturated fatty acid metabolic process(GO:0033559) |
0.1 | 8.5 | GO:0006310 | DNA recombination(GO:0006310) |
0.1 | 0.4 | GO:2000773 | negative regulation of cellular senescence(GO:2000773) |
0.1 | 1.3 | GO:0003081 | regulation of systemic arterial blood pressure by renin-angiotensin(GO:0003081) |
0.1 | 0.2 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
0.1 | 0.1 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.1 | 0.2 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.1 | 0.2 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
0.1 | 0.4 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.1 | 0.7 | GO:0030826 | regulation of cGMP biosynthetic process(GO:0030826) |
0.1 | 0.2 | GO:0046323 | glucose import(GO:0046323) |
0.1 | 0.4 | GO:1903077 | negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
0.1 | 0.1 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.1 | 0.9 | GO:0070542 | response to fatty acid(GO:0070542) |
0.1 | 0.2 | GO:0002583 | regulation of antigen processing and presentation of peptide antigen(GO:0002583) |
0.1 | 0.9 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
0.1 | 0.1 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.1 | 2.2 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
0.1 | 0.4 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.1 | 0.3 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.1 | 0.1 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.1 | 0.5 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.1 | 0.6 | GO:0032418 | lysosome localization(GO:0032418) |
0.1 | 0.3 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.1 | 0.2 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.1 | 0.1 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.1 | 0.4 | GO:0043276 | anoikis(GO:0043276) |
0.1 | 0.6 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.1 | 1.7 | GO:0007032 | endosome organization(GO:0007032) |
0.1 | 0.1 | GO:0042537 | benzene-containing compound metabolic process(GO:0042537) |
0.1 | 0.5 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.1 | 0.7 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.1 | 1.1 | GO:0019915 | lipid storage(GO:0019915) |
0.1 | 0.1 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.1 | 0.1 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.1 | 0.5 | GO:0009208 | pyrimidine ribonucleoside triphosphate metabolic process(GO:0009208) |
0.1 | 0.1 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.1 | 0.1 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.1 | 0.2 | GO:0045047 | protein targeting to ER(GO:0045047) |
0.1 | 1.2 | GO:0019835 | cytolysis(GO:0019835) |
0.1 | 0.2 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.1 | 0.2 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.1 | 0.2 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.1 | 4.1 | GO:1903749 | positive regulation of establishment of protein localization to mitochondrion(GO:1903749) |
0.1 | 0.5 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.1 | 1.1 | GO:0034629 | cellular protein complex localization(GO:0034629) |
0.1 | 0.1 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
0.1 | 0.4 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.1 | 0.6 | GO:0072583 | clathrin-mediated endocytosis(GO:0072583) |
0.1 | 0.4 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
0.1 | 0.7 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.1 | 1.0 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.1 | 1.4 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.1 | 0.3 | GO:0018002 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.1 | 0.2 | GO:0090181 | regulation of cholesterol metabolic process(GO:0090181) |
0.1 | 0.1 | GO:0010822 | positive regulation of mitochondrion organization(GO:0010822) |
0.1 | 0.1 | GO:0009180 | purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) |
0.1 | 0.2 | GO:0050755 | chemokine metabolic process(GO:0050755) |
0.1 | 1.1 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
0.1 | 0.1 | GO:0009247 | glycolipid biosynthetic process(GO:0009247) |
0.1 | 0.2 | GO:0043312 | neutrophil degranulation(GO:0043312) |
0.1 | 0.2 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
0.1 | 0.3 | GO:0015884 | folic acid transport(GO:0015884) |
0.1 | 0.1 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.1 | 0.3 | GO:0070986 | left/right axis specification(GO:0070986) |
0.1 | 1.5 | GO:0051297 | centrosome organization(GO:0051297) |
0.1 | 0.1 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.1 | 0.6 | GO:0010389 | regulation of G2/M transition of mitotic cell cycle(GO:0010389) |
0.1 | 0.6 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
0.1 | 0.2 | GO:0051450 | myoblast proliferation(GO:0051450) |
0.1 | 0.2 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.1 | 0.2 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.1 | 0.2 | GO:0015781 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
0.1 | 2.6 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.1 | 0.2 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
0.1 | 0.2 | GO:0014823 | response to activity(GO:0014823) |
0.1 | 0.2 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.1 | 0.1 | GO:0042511 | positive regulation of tyrosine phosphorylation of Stat1 protein(GO:0042511) |
0.1 | 0.1 | GO:1903209 | positive regulation of oxidative stress-induced cell death(GO:1903209) |
0.1 | 0.2 | GO:0031065 | positive regulation of histone deacetylation(GO:0031065) |
0.1 | 1.7 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.1 | 1.9 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
0.1 | 0.2 | GO:0002154 | thyroid hormone mediated signaling pathway(GO:0002154) |
0.1 | 0.1 | GO:1902608 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.1 | 0.2 | GO:1905097 | regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
0.1 | 0.1 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.1 | 0.2 | GO:0070235 | regulation of activation-induced cell death of T cells(GO:0070235) |
0.1 | 0.6 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.1 | 2.7 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.1 | 0.1 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
0.1 | 0.1 | GO:0060921 | sinoatrial node cell differentiation(GO:0060921) |
0.1 | 0.2 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.1 | 0.3 | GO:0015858 | nucleoside transport(GO:0015858) |
0.1 | 0.1 | GO:0003273 | cell migration involved in endocardial cushion formation(GO:0003273) |
0.1 | 0.6 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.1 | 0.1 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
0.1 | 0.2 | GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
0.1 | 0.2 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.1 | 0.1 | GO:0002431 | Fc receptor mediated stimulatory signaling pathway(GO:0002431) |
0.1 | 0.1 | GO:0007567 | parturition(GO:0007567) |
0.1 | 0.4 | GO:0033081 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
0.1 | 4.0 | GO:0000209 | protein polyubiquitination(GO:0000209) |
0.1 | 0.7 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.1 | 0.1 | GO:2000535 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.1 | 0.1 | GO:0044146 | negative regulation of growth of symbiont in host(GO:0044130) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
0.1 | 0.1 | GO:2000425 | regulation of apoptotic cell clearance(GO:2000425) |
0.1 | 0.5 | GO:0050655 | dermatan sulfate proteoglycan metabolic process(GO:0050655) |
0.1 | 0.1 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.1 | 11.7 | GO:0008380 | RNA splicing(GO:0008380) |
0.1 | 0.1 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.1 | 0.1 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.1 | 0.2 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.1 | 1.0 | GO:0043631 | mRNA polyadenylation(GO:0006378) RNA polyadenylation(GO:0043631) |
0.1 | 0.1 | GO:0002461 | tolerance induction dependent upon immune response(GO:0002461) |
0.1 | 2.3 | GO:0016573 | histone acetylation(GO:0016573) |
0.1 | 0.1 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.1 | 0.1 | GO:0060453 | regulation of gastric acid secretion(GO:0060453) negative regulation of gastric acid secretion(GO:0060455) |
0.1 | 0.1 | GO:0030885 | regulation of myeloid dendritic cell activation(GO:0030885) |
0.1 | 0.1 | GO:0061687 | detoxification of inorganic compound(GO:0061687) |
0.1 | 0.1 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.1 | 0.8 | GO:0010737 | protein kinase A signaling(GO:0010737) |
0.1 | 0.1 | GO:0034397 | telomere localization(GO:0034397) meiotic telomere clustering(GO:0045141) chromosome localization to nuclear envelope involved in homologous chromosome segregation(GO:0090220) |
0.1 | 0.1 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
0.1 | 0.1 | GO:0060037 | pharyngeal system development(GO:0060037) |
0.1 | 0.1 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
0.1 | 0.3 | GO:1904355 | positive regulation of telomere capping(GO:1904355) |
0.1 | 1.6 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.1 | 0.1 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.1 | 0.5 | GO:0050858 | negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) |
0.1 | 0.1 | GO:0051181 | cofactor transport(GO:0051181) |
0.1 | 1.3 | GO:0050729 | positive regulation of inflammatory response(GO:0050729) |
0.1 | 1.8 | GO:0006119 | oxidative phosphorylation(GO:0006119) |
0.1 | 0.2 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.1 | 0.2 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.1 | 0.2 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.1 | 0.5 | GO:0010827 | regulation of glucose transport(GO:0010827) |
0.1 | 0.1 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.1 | 0.8 | GO:0070527 | platelet aggregation(GO:0070527) |
0.1 | 0.1 | GO:0046686 | response to cadmium ion(GO:0046686) |
0.1 | 0.5 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.1 | 0.2 | GO:0006265 | DNA topological change(GO:0006265) |
0.1 | 0.1 | GO:0009750 | response to fructose(GO:0009750) cellular response to fructose stimulus(GO:0071332) |
0.1 | 0.5 | GO:0055092 | cholesterol homeostasis(GO:0042632) sterol homeostasis(GO:0055092) |
0.1 | 0.1 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.1 | 0.5 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
0.1 | 0.2 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.1 | 0.2 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.1 | 0.3 | GO:0045046 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.1 | 0.5 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.1 | 1.4 | GO:0008203 | cholesterol metabolic process(GO:0008203) |
0.1 | 0.1 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.1 | 0.1 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.1 | 0.1 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.1 | 0.6 | GO:0014037 | Schwann cell differentiation(GO:0014037) |
0.1 | 0.1 | GO:0045297 | mating plug formation(GO:0042628) single-organism reproductive behavior(GO:0044704) post-mating behavior(GO:0045297) |
0.1 | 0.4 | GO:0006862 | nucleotide transport(GO:0006862) |
0.1 | 0.1 | GO:0033572 | transferrin transport(GO:0033572) |
0.1 | 0.1 | GO:0002675 | positive regulation of acute inflammatory response(GO:0002675) |
0.1 | 1.0 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.1 | 0.1 | GO:0072224 | metanephric glomerulus development(GO:0072224) |
0.1 | 0.4 | GO:0061088 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.1 | 0.1 | GO:0002309 | T cell proliferation involved in immune response(GO:0002309) |
0.1 | 0.6 | GO:0021591 | ventricular system development(GO:0021591) |
0.1 | 0.2 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.1 | 0.1 | GO:0007184 | SMAD protein import into nucleus(GO:0007184) |
0.1 | 0.2 | GO:0032484 | Ral protein signal transduction(GO:0032484) |
0.1 | 0.2 | GO:0060972 | left/right pattern formation(GO:0060972) |
0.1 | 0.1 | GO:1901984 | negative regulation of protein acetylation(GO:1901984) |
0.1 | 0.1 | GO:1904353 | regulation of telomere capping(GO:1904353) |
0.1 | 0.1 | GO:0060920 | cardiac pacemaker cell differentiation(GO:0060920) |
0.1 | 0.1 | GO:0032532 | regulation of microvillus length(GO:0032532) |
0.1 | 0.1 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.1 | 0.6 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.1 | 0.1 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.1 | 1.1 | GO:0006338 | chromatin remodeling(GO:0006338) |
0.1 | 3.3 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.1 | 0.2 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.1 | 0.1 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.1 | 0.1 | GO:0097167 | response to ether(GO:0045472) circadian regulation of translation(GO:0097167) |
0.1 | 0.4 | GO:0045907 | positive regulation of vasoconstriction(GO:0045907) |
0.1 | 0.1 | GO:2000468 | regulation of peroxidase activity(GO:2000468) |
0.1 | 0.1 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
0.1 | 0.1 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
0.1 | 0.8 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.1 | 0.2 | GO:0009060 | aerobic respiration(GO:0009060) |
0.1 | 0.1 | GO:0006000 | fructose metabolic process(GO:0006000) |
0.1 | 0.1 | GO:0042640 | anagen(GO:0042640) |
0.1 | 0.1 | GO:0019081 | viral translation(GO:0019081) |
0.1 | 0.1 | GO:0042534 | tumor necrosis factor biosynthetic process(GO:0042533) regulation of tumor necrosis factor biosynthetic process(GO:0042534) |
0.1 | 0.2 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.1 | 0.3 | GO:0030033 | microvillus assembly(GO:0030033) |
0.1 | 0.3 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.1 | 0.1 | GO:0045822 | negative regulation of heart contraction(GO:0045822) |
0.1 | 0.1 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.1 | 0.1 | GO:0030575 | nuclear body organization(GO:0030575) |
0.1 | 0.4 | GO:0000303 | response to superoxide(GO:0000303) |
0.1 | 0.1 | GO:0071028 | nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
0.1 | 0.5 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.1 | 0.1 | GO:0070459 | prolactin secretion(GO:0070459) |
0.1 | 0.3 | GO:0033344 | cholesterol efflux(GO:0033344) |
0.1 | 0.1 | GO:0000578 | embryonic axis specification(GO:0000578) |
0.1 | 0.1 | GO:0018377 | protein myristoylation(GO:0018377) |
0.1 | 0.3 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.1 | 0.2 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.1 | 0.1 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
0.1 | 0.5 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
0.1 | 0.1 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.1 | 0.2 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.1 | 0.1 | GO:2000630 | positive regulation of miRNA metabolic process(GO:2000630) |
0.1 | 0.1 | GO:1904816 | positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
0.1 | 0.1 | GO:1900619 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.1 | 0.1 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.1 | 1.4 | GO:0016052 | carbohydrate catabolic process(GO:0016052) |
0.1 | 0.1 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.1 | 0.1 | GO:0010225 | response to UV-C(GO:0010225) |
0.1 | 0.5 | GO:0098781 | ncRNA transcription(GO:0098781) |
0.1 | 0.1 | GO:0032528 | microvillus organization(GO:0032528) |
0.1 | 0.2 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.1 | 0.1 | GO:0071321 | cellular response to cGMP(GO:0071321) |
0.1 | 0.4 | GO:0040018 | positive regulation of multicellular organism growth(GO:0040018) |
0.1 | 0.1 | GO:0002826 | negative regulation of T-helper 1 type immune response(GO:0002826) |
0.1 | 0.1 | GO:0002820 | negative regulation of adaptive immune response(GO:0002820) |
0.1 | 0.1 | GO:1905214 | regulation of mRNA binding(GO:1902415) regulation of RNA binding(GO:1905214) |
0.1 | 2.0 | GO:0006909 | phagocytosis(GO:0006909) |
0.1 | 0.1 | GO:0032647 | regulation of interferon-alpha production(GO:0032647) |
0.1 | 0.1 | GO:0014063 | negative regulation of serotonin secretion(GO:0014063) |
0.1 | 0.1 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.1 | 0.4 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
0.1 | 0.1 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.1 | 0.1 | GO:0036336 | dendritic cell migration(GO:0036336) |
0.1 | 0.1 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
0.1 | 0.1 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.1 | 0.5 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.1 | 0.2 | GO:2000737 | negative regulation of stem cell differentiation(GO:2000737) |
0.1 | 0.2 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
0.1 | 0.1 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.1 | 0.2 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.1 | 0.1 | GO:0035815 | positive regulation of renal sodium excretion(GO:0035815) |
0.0 | 0.0 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
0.0 | 0.0 | GO:0030823 | regulation of cGMP metabolic process(GO:0030823) |
0.0 | 0.0 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.0 | 0.5 | GO:1901099 | negative regulation of signal transduction in absence of ligand(GO:1901099) negative regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001240) |
0.0 | 0.9 | GO:2001234 | negative regulation of apoptotic signaling pathway(GO:2001234) |
0.0 | 0.0 | GO:0038001 | paracrine signaling(GO:0038001) |
0.0 | 0.2 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) |
0.0 | 0.1 | GO:0036233 | glycine import(GO:0036233) |
0.0 | 0.0 | GO:2000191 | regulation of fatty acid transport(GO:2000191) |
0.0 | 0.1 | GO:0002825 | regulation of T-helper 1 type immune response(GO:0002825) |
0.0 | 0.2 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.0 | 0.1 | GO:0071709 | membrane assembly(GO:0071709) |
0.0 | 0.0 | GO:0022904 | respiratory electron transport chain(GO:0022904) |
0.0 | 0.1 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
0.0 | 0.6 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.0 | 0.1 | GO:0086103 | G-protein coupled receptor signaling pathway involved in heart process(GO:0086103) |
0.0 | 0.5 | GO:0006289 | nucleotide-excision repair(GO:0006289) |
0.0 | 0.0 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.0 | 0.3 | GO:0051180 | vitamin transport(GO:0051180) |
0.0 | 0.1 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.0 | 0.2 | GO:2000252 | negative regulation of feeding behavior(GO:2000252) |
0.0 | 0.0 | GO:0090135 | actin filament branching(GO:0090135) |
0.0 | 0.1 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
0.0 | 0.0 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.0 | 0.0 | GO:0072718 | response to cisplatin(GO:0072718) |
0.0 | 0.3 | GO:0030168 | platelet activation(GO:0030168) |
0.0 | 0.1 | GO:0072678 | T cell migration(GO:0072678) |
0.0 | 0.0 | GO:0001820 | serotonin secretion(GO:0001820) |
0.0 | 0.3 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.0 | 0.6 | GO:0007052 | mitotic spindle organization(GO:0007052) |
0.0 | 0.1 | GO:0003085 | negative regulation of systemic arterial blood pressure(GO:0003085) |
0.0 | 0.1 | GO:0006090 | pyruvate metabolic process(GO:0006090) |
0.0 | 0.0 | GO:0048597 | post-embryonic camera-type eye morphogenesis(GO:0048597) |
0.0 | 0.1 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.0 | 0.2 | GO:0070633 | transepithelial transport(GO:0070633) |
0.0 | 0.5 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.0 | 0.1 | GO:0009414 | response to water deprivation(GO:0009414) |
0.0 | 0.3 | GO:0090305 | nucleic acid phosphodiester bond hydrolysis(GO:0090305) |
0.0 | 0.0 | GO:0072310 | glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
0.0 | 0.3 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.0 | 0.5 | GO:0006637 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
0.0 | 0.1 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.0 | 0.2 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.0 | 0.0 | GO:0006407 | rRNA export from nucleus(GO:0006407) |
0.0 | 0.3 | GO:0009250 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.0 | 0.3 | GO:0030193 | regulation of blood coagulation(GO:0030193) regulation of hemostasis(GO:1900046) |
0.0 | 0.0 | GO:2000698 | positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) |
0.0 | 0.3 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.0 | 0.0 | GO:0002444 | myeloid leukocyte mediated immunity(GO:0002444) |
0.0 | 0.0 | GO:2000479 | regulation of cAMP-dependent protein kinase activity(GO:2000479) |
0.0 | 0.3 | GO:0006801 | superoxide metabolic process(GO:0006801) |
0.0 | 0.1 | GO:0006921 | cellular component disassembly involved in execution phase of apoptosis(GO:0006921) apoptotic nuclear changes(GO:0030262) |
0.0 | 0.5 | GO:0032611 | interleukin-1 beta production(GO:0032611) |
0.0 | 0.1 | GO:0014889 | muscle atrophy(GO:0014889) |
0.0 | 0.0 | GO:0070673 | response to interleukin-18(GO:0070673) cellular response to interleukin-18(GO:0071351) |
0.0 | 0.2 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.0 | 0.2 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.0 | 0.0 | GO:0090520 | sphingolipid mediated signaling pathway(GO:0090520) |
0.0 | 0.1 | GO:0072673 | lamellipodium morphogenesis(GO:0072673) |
0.0 | 0.0 | GO:0044126 | regulation of growth of symbiont in host(GO:0044126) modulation of growth of symbiont involved in interaction with host(GO:0044144) |
0.0 | 0.1 | GO:0051894 | positive regulation of focal adhesion assembly(GO:0051894) |
0.0 | 0.0 | GO:0007412 | axon target recognition(GO:0007412) |
0.0 | 0.1 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.0 | 0.2 | GO:0055088 | lipid homeostasis(GO:0055088) |
0.0 | 0.0 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) |
0.0 | 0.3 | GO:0001675 | acrosome assembly(GO:0001675) |
0.0 | 0.0 | GO:0033685 | negative regulation of luteinizing hormone secretion(GO:0033685) |
0.0 | 0.1 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.0 | 0.1 | GO:0042503 | tyrosine phosphorylation of Stat3 protein(GO:0042503) |
0.0 | 0.0 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
0.0 | 0.0 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.0 | 0.0 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.0 | 1.0 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.0 | 0.0 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.0 | 0.2 | GO:0046427 | positive regulation of JAK-STAT cascade(GO:0046427) positive regulation of STAT cascade(GO:1904894) |
0.0 | 0.1 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.0 | 0.1 | GO:0045332 | phospholipid translocation(GO:0045332) |
0.0 | 0.1 | GO:0070417 | cellular response to cold(GO:0070417) |
0.0 | 0.0 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.0 | 0.0 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.0 | 0.1 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
0.0 | 0.3 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.0 | 0.1 | GO:0009191 | ribonucleoside diphosphate catabolic process(GO:0009191) |
0.0 | 0.0 | GO:0034204 | lipid translocation(GO:0034204) |
0.0 | 0.1 | GO:0001976 | neurological system process involved in regulation of systemic arterial blood pressure(GO:0001976) |
0.0 | 0.1 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.0 | 0.1 | GO:0097012 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
0.0 | 0.2 | GO:0019730 | antimicrobial humoral response(GO:0019730) |
0.0 | 0.0 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.0 | 0.0 | GO:0018393 | internal peptidyl-lysine acetylation(GO:0018393) |
0.0 | 2.0 | GO:0019439 | aromatic compound catabolic process(GO:0019439) |
0.0 | 0.2 | GO:1903727 | positive regulation of phospholipid metabolic process(GO:1903727) |
0.0 | 0.0 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
0.0 | 0.1 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.0 | 0.1 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.0 | 0.1 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.0 | 0.1 | GO:0032060 | bleb assembly(GO:0032060) |
0.0 | 0.2 | GO:1903859 | regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
0.0 | 0.1 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
0.0 | 0.6 | GO:0008286 | insulin receptor signaling pathway(GO:0008286) |
0.0 | 0.2 | GO:0035094 | response to nicotine(GO:0035094) |
0.0 | 0.2 | GO:0070613 | regulation of protein processing(GO:0070613) regulation of protein maturation(GO:1903317) |
0.0 | 0.3 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.0 | 0.1 | GO:0050687 | negative regulation of defense response to virus(GO:0050687) |
0.0 | 0.2 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
0.0 | 0.0 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
0.0 | 0.1 | GO:0061013 | regulation of mRNA catabolic process(GO:0061013) |
0.0 | 0.0 | GO:0035993 | deltoid tuberosity development(GO:0035993) |
0.0 | 0.7 | GO:0007189 | adenylate cyclase-activating G-protein coupled receptor signaling pathway(GO:0007189) |
0.0 | 0.7 | GO:0007030 | Golgi organization(GO:0007030) |
0.0 | 0.2 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.0 | 0.1 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.0 | 0.8 | GO:0003341 | cilium movement(GO:0003341) |
0.0 | 0.1 | GO:0050951 | sensory perception of temperature stimulus(GO:0050951) |
0.0 | 0.1 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.0 | 0.2 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.0 | 0.2 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.0 | 0.0 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.0 | 0.1 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.0 | 1.3 | GO:0050688 | regulation of defense response to virus(GO:0050688) |
0.0 | 0.1 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.0 | 0.0 | GO:0061085 | regulation of histone H3-K27 methylation(GO:0061085) positive regulation of histone H3-K27 methylation(GO:0061087) |
0.0 | 0.0 | GO:0042182 | ketone catabolic process(GO:0042182) |
0.0 | 0.2 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.0 | 0.2 | GO:0048169 | regulation of long-term neuronal synaptic plasticity(GO:0048169) |
0.0 | 0.0 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.0 | 0.0 | GO:0060749 | mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
0.0 | 0.1 | GO:0006040 | amino sugar metabolic process(GO:0006040) |
0.0 | 0.0 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.0 | 0.1 | GO:0006360 | transcription from RNA polymerase I promoter(GO:0006360) |
0.0 | 0.1 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.0 | 0.2 | GO:1901216 | positive regulation of neuron death(GO:1901216) |
0.0 | 0.1 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
0.0 | 0.0 | GO:0051446 | positive regulation of meiotic cell cycle(GO:0051446) |
0.0 | 0.5 | GO:0008643 | carbohydrate transport(GO:0008643) |
0.0 | 0.1 | GO:0042756 | drinking behavior(GO:0042756) |
0.0 | 0.1 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.0 | 0.1 | GO:0019532 | oxalate transport(GO:0019532) |
0.0 | 0.9 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
0.0 | 0.5 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.0 | 0.1 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
0.0 | 0.2 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.0 | 0.0 | GO:0016556 | mRNA modification(GO:0016556) |
0.0 | 0.1 | GO:0008356 | asymmetric cell division(GO:0008356) |
0.0 | 0.0 | GO:1904667 | negative regulation of ubiquitin protein ligase activity(GO:1904667) |
0.0 | 0.0 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.0 | 0.0 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
0.0 | 0.0 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.0 | 0.1 | GO:0050891 | multicellular organismal water homeostasis(GO:0050891) |
0.0 | 0.0 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.0 | 0.1 | GO:0010529 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.0 | 0.0 | GO:0006971 | hypotonic response(GO:0006971) |
0.0 | 0.1 | GO:0044380 | protein localization to cytoskeleton(GO:0044380) |
0.0 | 0.1 | GO:0060761 | negative regulation of response to cytokine stimulus(GO:0060761) |
0.0 | 0.1 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.0 | 0.0 | GO:0048162 | preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) |
0.0 | 0.1 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.0 | 0.9 | GO:0043627 | response to estrogen(GO:0043627) |
0.0 | 0.1 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.0 | 0.0 | GO:0042398 | cellular modified amino acid biosynthetic process(GO:0042398) |
0.0 | 0.6 | GO:1903305 | regulation of regulated secretory pathway(GO:1903305) |
0.0 | 0.0 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.0 | 0.1 | GO:0034724 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
0.0 | 0.0 | GO:0021558 | trochlear nerve development(GO:0021558) |
0.0 | 0.1 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.0 | 0.6 | GO:0002323 | natural killer cell activation involved in immune response(GO:0002323) |
0.0 | 0.0 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.0 | 0.3 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.0 | 0.0 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.0 | 0.0 | GO:1901894 | regulation of calcium-transporting ATPase activity(GO:1901894) |
0.0 | 0.0 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.0 | 0.0 | GO:0036465 | synaptic vesicle recycling(GO:0036465) |
0.0 | 0.1 | GO:0014046 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.0 | 0.0 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.0 | 0.0 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.0 | 0.0 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.0 | 0.1 | GO:0046676 | negative regulation of insulin secretion(GO:0046676) |
0.0 | 0.1 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.0 | 0.2 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.0 | 0.0 | GO:0006760 | folic acid-containing compound metabolic process(GO:0006760) |
0.0 | 0.0 | GO:1902003 | regulation of beta-amyloid formation(GO:1902003) |
0.0 | 0.0 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.0 | 0.0 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.0 | 0.0 | GO:0032439 | endosome localization(GO:0032439) |
0.0 | 0.2 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.0 | 0.0 | GO:0009597 | detection of virus(GO:0009597) |
0.0 | 0.0 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.0 | 0.0 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
0.0 | 0.0 | GO:1902041 | regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902041) |
0.0 | 0.0 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.0 | 0.0 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.0 | 0.0 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.0 | 0.0 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.0 | 0.1 | GO:0016180 | snRNA processing(GO:0016180) |
0.0 | 0.0 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.0 | 0.0 | GO:0090185 | negative regulation of kidney development(GO:0090185) |
0.0 | 0.0 | GO:2001198 | regulation of dendritic cell differentiation(GO:2001198) |
0.0 | 0.1 | GO:0007129 | synapsis(GO:0007129) |
0.0 | 0.0 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.0 | 0.0 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.0 | 1.2 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.4 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.0 | 12.4 | GO:0007606 | sensory perception of chemical stimulus(GO:0007606) |
0.0 | 0.0 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
0.0 | 0.0 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
0.0 | 0.0 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.0 | 0.0 | GO:0048935 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.0 | 6.1 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
2.0 | 14.3 | GO:0005577 | fibrinogen complex(GO:0005577) |
1.8 | 8.9 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
1.8 | 10.6 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
1.6 | 6.3 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
1.6 | 4.7 | GO:0097451 | glial limiting end-foot(GO:0097451) |
1.4 | 7.2 | GO:0005579 | membrane attack complex(GO:0005579) |
1.4 | 8.1 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
1.2 | 4.9 | GO:1990130 | Iml1 complex(GO:1990130) |
1.1 | 4.5 | GO:0005955 | calcineurin complex(GO:0005955) |
1.1 | 6.6 | GO:0005796 | Golgi lumen(GO:0005796) |
1.1 | 21.9 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
1.0 | 3.1 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.9 | 4.7 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.9 | 3.6 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.9 | 2.6 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.9 | 5.1 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.8 | 1.6 | GO:0032127 | dense core granule membrane(GO:0032127) |
0.8 | 4.9 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.8 | 1.6 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.8 | 3.2 | GO:0097433 | dense body(GO:0097433) |
0.8 | 2.4 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.8 | 0.8 | GO:1903349 | omegasome membrane(GO:1903349) |
0.8 | 10.1 | GO:0036038 | MKS complex(GO:0036038) |
0.7 | 2.2 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.7 | 2.2 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.7 | 2.1 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.7 | 6.4 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.7 | 7.8 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.7 | 2.8 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.7 | 2.1 | GO:0042585 | germinal vesicle(GO:0042585) |
0.7 | 2.1 | GO:0031417 | NatC complex(GO:0031417) |
0.7 | 3.3 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.7 | 3.3 | GO:0045261 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.7 | 0.7 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.7 | 2.6 | GO:0098536 | deuterosome(GO:0098536) |
0.7 | 2.0 | GO:0035061 | interchromatin granule(GO:0035061) |
0.6 | 9.7 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.6 | 3.9 | GO:0001739 | sex chromatin(GO:0001739) |
0.6 | 0.6 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.6 | 0.6 | GO:0032010 | phagolysosome(GO:0032010) |
0.6 | 1.9 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.6 | 0.6 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.6 | 6.7 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.6 | 2.4 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
0.6 | 6.6 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.6 | 6.6 | GO:0032797 | SMN complex(GO:0032797) |
0.6 | 4.6 | GO:0045179 | apical cortex(GO:0045179) |
0.6 | 1.7 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.6 | 6.2 | GO:0044798 | nuclear transcription factor complex(GO:0044798) |
0.6 | 1.7 | GO:0031523 | Myb complex(GO:0031523) |
0.5 | 1.6 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.5 | 1.6 | GO:0097443 | sorting endosome(GO:0097443) |
0.5 | 4.2 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.5 | 2.6 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.5 | 9.3 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.5 | 4.1 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
0.5 | 2.0 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.5 | 30.1 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.5 | 4.0 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.5 | 2.0 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.5 | 1.5 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.5 | 2.0 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.5 | 4.4 | GO:0036128 | CatSper complex(GO:0036128) |
0.5 | 20.7 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.5 | 2.9 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.5 | 0.9 | GO:0044393 | microspike(GO:0044393) |
0.5 | 3.3 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.5 | 0.5 | GO:0044455 | mitochondrial membrane part(GO:0044455) |
0.5 | 4.5 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.5 | 1.4 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.5 | 2.3 | GO:0031983 | vesicle lumen(GO:0031983) |
0.5 | 1.4 | GO:0000811 | GINS complex(GO:0000811) |
0.4 | 2.2 | GO:0016528 | sarcoplasm(GO:0016528) |
0.4 | 3.1 | GO:0031931 | TORC1 complex(GO:0031931) |
0.4 | 1.8 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.4 | 2.2 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.4 | 13.7 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.4 | 0.4 | GO:0016939 | kinesin II complex(GO:0016939) |
0.4 | 1.3 | GO:0030478 | actin cap(GO:0030478) |
0.4 | 0.9 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.4 | 1.3 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.4 | 4.3 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.4 | 2.1 | GO:0005683 | U7 snRNP(GO:0005683) |
0.4 | 14.7 | GO:0016592 | mediator complex(GO:0016592) |
0.4 | 2.0 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.4 | 0.8 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.4 | 0.4 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.4 | 1.2 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.4 | 34.8 | GO:0072562 | blood microparticle(GO:0072562) |
0.4 | 2.4 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.4 | 5.5 | GO:0001891 | phagocytic cup(GO:0001891) |
0.4 | 3.2 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.4 | 0.8 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
0.4 | 1.6 | GO:0070545 | PeBoW complex(GO:0070545) |
0.4 | 9.2 | GO:0012505 | endomembrane system(GO:0012505) |
0.4 | 0.4 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.4 | 4.9 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.4 | 1.5 | GO:0045298 | tubulin complex(GO:0045298) |
0.4 | 2.2 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
0.4 | 1.5 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.4 | 0.4 | GO:0005767 | secondary lysosome(GO:0005767) |
0.4 | 3.6 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.4 | 1.1 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.3 | 8.0 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.3 | 1.0 | GO:0031932 | TORC2 complex(GO:0031932) |
0.3 | 2.1 | GO:0001940 | male pronucleus(GO:0001940) |
0.3 | 3.1 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.3 | 3.1 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.3 | 1.4 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.3 | 0.7 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.3 | 2.3 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.3 | 0.7 | GO:1990923 | PET complex(GO:1990923) |
0.3 | 13.5 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.3 | 44.5 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.3 | 1.3 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.3 | 7.6 | GO:0015030 | Cajal body(GO:0015030) |
0.3 | 2.6 | GO:0016600 | flotillin complex(GO:0016600) |
0.3 | 3.2 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.3 | 1.0 | GO:0008287 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
0.3 | 1.6 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.3 | 1.6 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.3 | 3.7 | GO:0042581 | specific granule(GO:0042581) |
0.3 | 14.5 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.3 | 0.3 | GO:0098827 | endoplasmic reticulum subcompartment(GO:0098827) |
0.3 | 0.3 | GO:0005686 | U2 snRNP(GO:0005686) |
0.3 | 1.2 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.3 | 3.3 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.3 | 0.9 | GO:0097413 | Lewy body(GO:0097413) |
0.3 | 1.5 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.3 | 1.5 | GO:0000796 | condensin complex(GO:0000796) |
0.3 | 0.9 | GO:0000805 | X chromosome(GO:0000805) |
0.3 | 1.2 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.3 | 0.9 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.3 | 1.4 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.3 | 0.3 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.3 | 1.7 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.3 | 1.1 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.3 | 2.3 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.3 | 0.9 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.3 | 1.7 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.3 | 1.4 | GO:0097422 | tubular endosome(GO:0097422) |
0.3 | 1.4 | GO:0071012 | catalytic step 1 spliceosome(GO:0071012) |
0.3 | 7.3 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.3 | 3.7 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.3 | 1.1 | GO:0005915 | zonula adherens(GO:0005915) |
0.3 | 1.4 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.3 | 4.4 | GO:0030904 | retromer complex(GO:0030904) |
0.3 | 0.5 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.3 | 1.6 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.3 | 1.6 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.3 | 0.8 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.3 | 1.6 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.3 | 4.8 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.3 | 5.6 | GO:0034451 | centriolar satellite(GO:0034451) |
0.3 | 7.9 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.3 | 1.8 | GO:0071439 | clathrin complex(GO:0071439) |
0.3 | 17.2 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.3 | 4.9 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.3 | 0.3 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.3 | 1.5 | GO:0044292 | dendrite terminus(GO:0044292) |
0.3 | 2.3 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.3 | 0.3 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.2 | 2.7 | GO:0005675 | holo TFIIH complex(GO:0005675) |
0.2 | 1.7 | GO:0060091 | kinocilium(GO:0060091) |
0.2 | 1.0 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.2 | 2.5 | GO:0031143 | pseudopodium(GO:0031143) |
0.2 | 3.7 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.2 | 2.2 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.2 | 2.2 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.2 | 5.6 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.2 | 1.0 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.2 | 4.1 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.2 | 1.2 | GO:0097255 | R2TP complex(GO:0097255) |
0.2 | 0.7 | GO:0034358 | plasma lipoprotein particle(GO:0034358) lipoprotein particle(GO:1990777) |
0.2 | 4.3 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.2 | 0.5 | GO:0031261 | DNA replication preinitiation complex(GO:0031261) |
0.2 | 1.0 | GO:0031512 | motile primary cilium(GO:0031512) |
0.2 | 0.2 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.2 | 0.9 | GO:0051286 | cell tip(GO:0051286) |
0.2 | 4.2 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.2 | 3.0 | GO:0000242 | pericentriolar material(GO:0000242) |
0.2 | 0.9 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.2 | 8.0 | GO:0005762 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.2 | 3.4 | GO:0000145 | exocyst(GO:0000145) |
0.2 | 0.7 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.2 | 0.4 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.2 | 2.9 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.2 | 0.4 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.2 | 6.4 | GO:0005876 | spindle microtubule(GO:0005876) |
0.2 | 1.1 | GO:0005685 | U1 snRNP(GO:0005685) |
0.2 | 0.2 | GO:0002139 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) |
0.2 | 0.7 | GO:0097452 | GAIT complex(GO:0097452) |
0.2 | 0.2 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.2 | 0.6 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.2 | 3.0 | GO:0005682 | U5 snRNP(GO:0005682) |
0.2 | 1.9 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.2 | 1.3 | GO:0000243 | commitment complex(GO:0000243) |
0.2 | 0.2 | GO:0042583 | chromaffin granule(GO:0042583) |
0.2 | 1.0 | GO:0005638 | lamin filament(GO:0005638) |
0.2 | 4.4 | GO:0005771 | multivesicular body(GO:0005771) |
0.2 | 0.2 | GO:0005642 | annulate lamellae(GO:0005642) |
0.2 | 1.2 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.2 | 1.0 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
0.2 | 1.6 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.2 | 1.2 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.2 | 1.6 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.2 | 8.9 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.2 | 11.0 | GO:0043197 | dendritic spine(GO:0043197) |
0.2 | 0.4 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.2 | 8.4 | GO:0032587 | ruffle membrane(GO:0032587) |
0.2 | 30.4 | GO:0000139 | Golgi membrane(GO:0000139) |
0.2 | 0.4 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.2 | 0.6 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.2 | 1.3 | GO:0042382 | paraspeckles(GO:0042382) |
0.2 | 2.8 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.2 | 4.0 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.2 | 2.1 | GO:0005839 | proteasome core complex(GO:0005839) |
0.2 | 1.3 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.2 | 4.5 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.2 | 4.1 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.2 | 1.1 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.2 | 0.6 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.2 | 3.5 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.2 | 1.6 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.2 | 2.4 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.2 | 2.2 | GO:1904949 | ATPase complex(GO:1904949) |
0.2 | 4.5 | GO:0005938 | cell cortex(GO:0005938) |
0.2 | 9.4 | GO:0005643 | nuclear pore(GO:0005643) |
0.2 | 55.4 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.2 | 0.4 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.2 | 8.0 | GO:0016363 | nuclear matrix(GO:0016363) |
0.2 | 0.4 | GO:0019814 | immunoglobulin complex(GO:0019814) |
0.2 | 3.0 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.2 | 1.1 | GO:0071437 | invadopodium(GO:0071437) |
0.2 | 4.1 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.2 | 0.7 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.2 | 1.2 | GO:0070938 | contractile ring(GO:0070938) |
0.2 | 6.7 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.2 | 1.4 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.2 | 0.4 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.2 | 0.4 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.2 | 0.2 | GO:0032994 | protein-lipid complex(GO:0032994) |
0.2 | 1.4 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.2 | 0.2 | GO:1990423 | RZZ complex(GO:1990423) |
0.2 | 6.4 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.2 | 1.9 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.2 | 5.1 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.2 | 0.5 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.2 | 0.2 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.2 | 0.5 | GO:0005684 | U2-type spliceosomal complex(GO:0005684) |
0.2 | 1.2 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.2 | 0.2 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.2 | 3.7 | GO:0005776 | autophagosome(GO:0005776) |
0.2 | 1.3 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.2 | 0.3 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.2 | 0.5 | GO:0070069 | cytochrome complex(GO:0070069) |
0.2 | 1.2 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.2 | 0.5 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.2 | 1.5 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.2 | 2.6 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.2 | 0.5 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.2 | 1.7 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.2 | 0.8 | GO:0071546 | pi-body(GO:0071546) |
0.2 | 2.2 | GO:0033176 | proton-transporting V-type ATPase complex(GO:0033176) |
0.2 | 1.7 | GO:0031528 | microvillus membrane(GO:0031528) |
0.2 | 0.5 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.2 | 0.6 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.2 | 1.1 | GO:0031209 | SCAR complex(GO:0031209) |
0.2 | 9.4 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.2 | 2.1 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.2 | 1.2 | GO:0042587 | glycogen granule(GO:0042587) |
0.2 | 5.9 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.2 | 0.2 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
0.1 | 0.3 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.1 | 0.9 | GO:0019908 | nuclear cyclin-dependent protein kinase holoenzyme complex(GO:0019908) |
0.1 | 0.4 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.1 | 3.5 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.1 | 2.6 | GO:0035861 | site of double-strand break(GO:0035861) |
0.1 | 0.3 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.1 | 0.3 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.1 | 3.8 | GO:0045171 | intercellular bridge(GO:0045171) |
0.1 | 0.4 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.1 | 1.3 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
0.1 | 0.1 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.1 | 0.6 | GO:0030057 | desmosome(GO:0030057) |
0.1 | 0.6 | GO:0070876 | SOSS complex(GO:0070876) |
0.1 | 1.0 | GO:0035102 | PRC1 complex(GO:0035102) |
0.1 | 1.7 | GO:0043205 | fibril(GO:0043205) |
0.1 | 1.1 | GO:0005838 | proteasome regulatory particle(GO:0005838) |
0.1 | 2.8 | GO:0031526 | brush border membrane(GO:0031526) |
0.1 | 6.1 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 0.3 | GO:0045120 | pronucleus(GO:0045120) |
0.1 | 0.7 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.1 | 0.7 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.1 | 1.5 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.1 | 5.8 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.1 | 0.1 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.1 | 0.1 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.1 | 0.8 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.1 | 2.1 | GO:0022626 | cytosolic ribosome(GO:0022626) |
0.1 | 0.3 | GO:0048179 | activin receptor complex(GO:0048179) |
0.1 | 9.7 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.1 | 0.5 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.1 | 4.7 | GO:0000922 | spindle pole(GO:0000922) |
0.1 | 1.0 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.1 | 0.6 | GO:0005883 | neurofilament(GO:0005883) |
0.1 | 1.1 | GO:0002102 | podosome(GO:0002102) |
0.1 | 0.9 | GO:0005874 | microtubule(GO:0005874) |
0.1 | 4.8 | GO:0016605 | PML body(GO:0016605) |
0.1 | 1.7 | GO:0000502 | proteasome complex(GO:0000502) |
0.1 | 0.1 | GO:0097427 | microtubule bundle(GO:0097427) |
0.1 | 0.1 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.1 | 0.7 | GO:0048500 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.1 | 104.8 | GO:0005739 | mitochondrion(GO:0005739) |
0.1 | 2.2 | GO:0016235 | aggresome(GO:0016235) |
0.1 | 0.4 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 0.1 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.1 | 0.1 | GO:0034399 | nuclear periphery(GO:0034399) |
0.1 | 0.2 | GO:0089701 | U2AF(GO:0089701) |
0.1 | 0.5 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.1 | 15.1 | GO:0005813 | centrosome(GO:0005813) |
0.1 | 109.9 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.1 | 1.3 | GO:0071565 | nBAF complex(GO:0071565) |
0.1 | 0.3 | GO:0001650 | fibrillar center(GO:0001650) |
0.1 | 0.1 | GO:0016234 | inclusion body(GO:0016234) |
0.1 | 4.2 | GO:0055037 | recycling endosome(GO:0055037) |
0.1 | 1.8 | GO:0005903 | brush border(GO:0005903) |
0.1 | 0.2 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.1 | 0.3 | GO:0036156 | inner dynein arm(GO:0036156) |
0.1 | 0.1 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.1 | 1.3 | GO:0031901 | early endosome membrane(GO:0031901) |
0.1 | 2.0 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.1 | 3.6 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.1 | 0.1 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.1 | 1.2 | GO:0031982 | vesicle(GO:0031982) |
0.1 | 7.7 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.1 | 2.4 | GO:0016591 | DNA-directed RNA polymerase II, holoenzyme(GO:0016591) |
0.1 | 0.5 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.1 | 0.5 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.1 | 0.2 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.1 | 0.6 | GO:0031415 | NatA complex(GO:0031415) |
0.1 | 0.1 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
0.1 | 5.0 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 0.2 | GO:0045178 | basal part of cell(GO:0045178) |
0.1 | 2.4 | GO:0000795 | synaptonemal complex(GO:0000795) |
0.1 | 0.5 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.1 | 0.5 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 0.1 | GO:0071986 | Ragulator complex(GO:0071986) |
0.1 | 0.1 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.1 | 0.8 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.1 | 0.5 | GO:0030894 | replisome(GO:0030894) |
0.1 | 0.4 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.1 | 0.2 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.1 | 13.9 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.1 | 0.9 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.1 | 0.1 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.1 | 0.1 | GO:0055087 | Ski complex(GO:0055087) |
0.1 | 0.3 | GO:0001652 | granular component(GO:0001652) |
0.1 | 3.2 | GO:0000123 | histone acetyltransferase complex(GO:0000123) |
0.1 | 0.2 | GO:0033270 | paranode region of axon(GO:0033270) |
0.1 | 0.9 | GO:0060170 | ciliary membrane(GO:0060170) |
0.1 | 0.3 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.1 | 0.9 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.1 | 1.0 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.1 | 0.3 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.1 | 0.9 | GO:0010008 | endosome membrane(GO:0010008) |
0.1 | 0.2 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.1 | 13.0 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.1 | 0.5 | GO:0016459 | myosin complex(GO:0016459) |
0.1 | 0.2 | GO:0000812 | Swr1 complex(GO:0000812) |
0.1 | 5.5 | GO:0005635 | nuclear envelope(GO:0005635) |
0.1 | 0.3 | GO:0005914 | spot adherens junction(GO:0005914) |
0.1 | 115.2 | GO:0070062 | extracellular exosome(GO:0070062) |
0.1 | 0.2 | GO:0033263 | CORVET complex(GO:0033263) |
0.1 | 5.9 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
0.1 | 0.2 | GO:0033269 | internode region of axon(GO:0033269) |
0.1 | 0.4 | GO:0030496 | midbody(GO:0030496) |
0.1 | 0.3 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.1 | 0.2 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.1 | 0.7 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.1 | 0.2 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.1 | 0.3 | GO:0031514 | motile cilium(GO:0031514) |
0.1 | 0.2 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
0.1 | 1.1 | GO:0097228 | sperm principal piece(GO:0097228) |
0.1 | 4.4 | GO:0016604 | nuclear body(GO:0016604) |
0.1 | 1.3 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.1 | 0.6 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.1 | 2.1 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.1 | 0.1 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.1 | 0.1 | GO:0071564 | npBAF complex(GO:0071564) |
0.1 | 4.9 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.1 | 0.4 | GO:0070652 | HAUS complex(GO:0070652) |
0.1 | 0.1 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.1 | 1.5 | GO:0005884 | actin filament(GO:0005884) |
0.1 | 2.0 | GO:0000793 | condensed chromosome(GO:0000793) |
0.1 | 0.1 | GO:0097470 | ribbon synapse(GO:0097470) |
0.1 | 0.2 | GO:0016342 | catenin complex(GO:0016342) |
0.1 | 0.1 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.1 | 0.3 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.1 | 1.9 | GO:0005819 | spindle(GO:0005819) |
0.1 | 2.8 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.1 | 0.2 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
0.1 | 0.5 | GO:1902555 | endoribonuclease complex(GO:1902555) |
0.1 | 0.2 | GO:0097225 | sperm midpiece(GO:0097225) |
0.1 | 0.1 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.1 | 0.1 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.1 | 0.8 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.1 | 0.2 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.1 | 0.4 | GO:0033202 | DNA helicase complex(GO:0033202) |
0.1 | 0.1 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.1 | 0.2 | GO:0030897 | HOPS complex(GO:0030897) |
0.1 | 39.0 | GO:0005654 | nucleoplasm(GO:0005654) |
0.1 | 0.2 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.1 | 0.8 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.1 | 0.1 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.0 | 0.2 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.0 | 1.4 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
0.0 | 0.0 | GO:0072534 | perineuronal net(GO:0072534) |
0.0 | 0.0 | GO:0097525 | spliceosomal snRNP complex(GO:0097525) |
0.0 | 0.3 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.0 | 0.0 | GO:0030891 | VCB complex(GO:0030891) |
0.0 | 0.1 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.0 | 0.0 | GO:0030880 | RNA polymerase complex(GO:0030880) |
0.0 | 0.1 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.0 | 0.1 | GO:0030027 | lamellipodium(GO:0030027) |
0.0 | 0.0 | GO:0000346 | transcription export complex(GO:0000346) |
0.0 | 0.2 | GO:0032426 | stereocilium tip(GO:0032426) |
0.0 | 15.0 | GO:0005829 | cytosol(GO:0005829) |
0.0 | 4.6 | GO:0005694 | chromosome(GO:0005694) |
0.0 | 0.3 | GO:0043196 | varicosity(GO:0043196) |
0.0 | 0.0 | GO:0043218 | compact myelin(GO:0043218) |
0.0 | 0.3 | GO:0005861 | troponin complex(GO:0005861) |
0.0 | 0.4 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.0 | 3.1 | GO:0005667 | transcription factor complex(GO:0005667) |
0.0 | 0.2 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.0 | 0.0 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.0 | 0.8 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.0 | 0.1 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.0 | 0.0 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.0 | 0.2 | GO:0005902 | microvillus(GO:0005902) |
0.0 | 50.8 | GO:0005737 | cytoplasm(GO:0005737) |
0.0 | 0.0 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.0 | 0.9 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 36.4 | GO:0016021 | integral component of membrane(GO:0016021) |
0.0 | 1.1 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.0 | 8.9 | GO:0046573 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
2.7 | 10.9 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
2.6 | 7.7 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
2.4 | 7.3 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
2.1 | 6.4 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
2.0 | 6.1 | GO:0015205 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
2.0 | 8.1 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
2.0 | 6.0 | GO:0030620 | U2 snRNA binding(GO:0030620) |
1.9 | 5.6 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
1.8 | 1.8 | GO:0070538 | oleic acid binding(GO:0070538) |
1.8 | 12.6 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
1.7 | 6.7 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
1.6 | 4.9 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
1.6 | 6.5 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
1.6 | 9.4 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
1.3 | 5.3 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
1.3 | 4.0 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
1.3 | 1.3 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
1.2 | 2.5 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
1.2 | 9.7 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
1.2 | 3.6 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
1.2 | 3.5 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
1.2 | 3.5 | GO:0030350 | iron-responsive element binding(GO:0030350) |
1.1 | 5.5 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
1.1 | 8.8 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
1.1 | 9.9 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
1.1 | 19.5 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
1.1 | 4.2 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
1.0 | 1.0 | GO:0018423 | protein C-terminal leucine carboxyl O-methyltransferase activity(GO:0018423) |
1.0 | 4.1 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
1.0 | 6.1 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
1.0 | 3.0 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
1.0 | 3.0 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
1.0 | 2.9 | GO:0015154 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
1.0 | 2.9 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
1.0 | 3.9 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
1.0 | 4.8 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.9 | 2.8 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.9 | 2.8 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.9 | 2.8 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.9 | 3.7 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.9 | 1.9 | GO:0050692 | DBD domain binding(GO:0050692) |
0.9 | 10.2 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.9 | 4.6 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.9 | 2.7 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.9 | 2.7 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.9 | 3.6 | GO:0045340 | mercury ion binding(GO:0045340) |
0.9 | 0.9 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.9 | 4.4 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.9 | 3.5 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.9 | 3.5 | GO:0009374 | biotin binding(GO:0009374) |
0.9 | 2.6 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.9 | 9.4 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.9 | 3.4 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.8 | 4.2 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.8 | 0.8 | GO:0042054 | histone methyltransferase activity(GO:0042054) |
0.8 | 3.3 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.8 | 2.5 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.8 | 8.0 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.8 | 2.3 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.8 | 5.4 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.8 | 11.6 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.8 | 5.4 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.8 | 4.6 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.8 | 2.3 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.8 | 0.8 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.7 | 6.0 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.7 | 2.9 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.7 | 8.8 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.7 | 2.9 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.7 | 2.2 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.7 | 5.8 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.7 | 2.2 | GO:0019862 | IgA binding(GO:0019862) |
0.7 | 2.1 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.7 | 7.9 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.7 | 3.6 | GO:0002054 | nucleobase binding(GO:0002054) |
0.7 | 2.8 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.7 | 8.5 | GO:0019841 | retinol binding(GO:0019841) |
0.7 | 5.6 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.7 | 2.8 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.7 | 6.8 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.7 | 0.7 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.7 | 4.7 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.7 | 6.0 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.7 | 2.0 | GO:0080130 | L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
0.7 | 2.0 | GO:0005119 | smoothened binding(GO:0005119) |
0.7 | 1.3 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.6 | 1.3 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
0.6 | 1.9 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
0.6 | 3.0 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.6 | 2.4 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.6 | 0.6 | GO:0016918 | retinal binding(GO:0016918) |
0.6 | 3.6 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.6 | 1.8 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.6 | 4.2 | GO:0046790 | virion binding(GO:0046790) |
0.6 | 3.6 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.6 | 1.8 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.6 | 2.9 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.6 | 4.1 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.6 | 0.6 | GO:0016015 | morphogen activity(GO:0016015) |
0.6 | 2.9 | GO:0004556 | alpha-amylase activity(GO:0004556) |
0.6 | 1.7 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.6 | 2.9 | GO:0015189 | arginine transmembrane transporter activity(GO:0015181) L-lysine transmembrane transporter activity(GO:0015189) |
0.6 | 2.9 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.6 | 2.8 | GO:0070728 | leucine binding(GO:0070728) |
0.6 | 1.7 | GO:0051718 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
0.6 | 18.5 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.6 | 2.2 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.6 | 7.8 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.5 | 10.4 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.5 | 4.4 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.5 | 1.6 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.5 | 4.3 | GO:0033677 | DNA/RNA helicase activity(GO:0033677) |
0.5 | 3.7 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.5 | 3.2 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) |
0.5 | 1.6 | GO:0050693 | LBD domain binding(GO:0050693) |
0.5 | 2.1 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.5 | 1.5 | GO:0004064 | arylesterase activity(GO:0004064) |
0.5 | 9.3 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.5 | 2.1 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.5 | 3.5 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.5 | 2.0 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.5 | 6.0 | GO:0015643 | toxic substance binding(GO:0015643) |
0.5 | 1.5 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.5 | 1.0 | GO:0036137 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.5 | 2.0 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.5 | 0.5 | GO:0001884 | pyrimidine nucleoside binding(GO:0001884) |
0.5 | 2.4 | GO:0032558 | adenyl deoxyribonucleotide binding(GO:0032558) |
0.5 | 0.5 | GO:0089720 | caspase binding(GO:0089720) |
0.5 | 1.0 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.5 | 4.4 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
0.5 | 52.7 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.5 | 7.3 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.5 | 24.5 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.5 | 1.9 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.5 | 7.0 | GO:0005521 | lamin binding(GO:0005521) |
0.5 | 1.9 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.5 | 0.9 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
0.5 | 4.1 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.5 | 1.4 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.5 | 1.4 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.5 | 5.9 | GO:0010181 | FMN binding(GO:0010181) |
0.5 | 2.7 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.5 | 2.7 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.4 | 1.8 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.4 | 3.1 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.4 | 1.3 | GO:0019002 | GMP binding(GO:0019002) |
0.4 | 2.2 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.4 | 0.9 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.4 | 1.3 | GO:0004103 | choline kinase activity(GO:0004103) |
0.4 | 0.9 | GO:0035276 | ethanol binding(GO:0035276) |
0.4 | 1.3 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.4 | 2.6 | GO:0019203 | carbohydrate phosphatase activity(GO:0019203) sugar-phosphatase activity(GO:0050308) |
0.4 | 2.5 | GO:0034785 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) tocotrienol omega-hydroxylase activity(GO:0052872) thalianol hydroxylase activity(GO:0080014) |
0.4 | 0.4 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
0.4 | 19.5 | GO:0008392 | arachidonic acid epoxygenase activity(GO:0008392) |
0.4 | 1.3 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.4 | 2.1 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.4 | 1.3 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.4 | 0.8 | GO:0051425 | PTB domain binding(GO:0051425) |
0.4 | 1.7 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.4 | 2.1 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.4 | 3.3 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.4 | 1.2 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.4 | 2.8 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.4 | 1.2 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.4 | 4.0 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.4 | 2.8 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.4 | 6.4 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.4 | 0.8 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.4 | 0.4 | GO:0046978 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.4 | 2.4 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.4 | 2.0 | GO:0000150 | recombinase activity(GO:0000150) |
0.4 | 0.4 | GO:0052827 | inositol-1,3,4,5,6-pentakisphosphate 3-phosphatase activity(GO:0030351) inositol-1,4,5,6-tetrakisphosphate 6-phosphatase activity(GO:0030352) inositol pentakisphosphate phosphatase activity(GO:0052827) |
0.4 | 4.3 | GO:0015250 | water channel activity(GO:0015250) |
0.4 | 2.0 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.4 | 2.0 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.4 | 1.6 | GO:0030572 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) |
0.4 | 0.8 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.4 | 1.2 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.4 | 0.4 | GO:0016725 | oxidoreductase activity, acting on CH or CH2 groups(GO:0016725) |
0.4 | 1.2 | GO:0070905 | serine binding(GO:0070905) |
0.4 | 1.9 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.4 | 1.5 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.4 | 1.2 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.4 | 5.3 | GO:0008483 | transaminase activity(GO:0008483) |
0.4 | 3.8 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.4 | 0.4 | GO:0030792 | methylarsonite methyltransferase activity(GO:0030792) |
0.4 | 1.1 | GO:0004096 | catalase activity(GO:0004096) |
0.4 | 0.4 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.4 | 0.7 | GO:0031720 | haptoglobin binding(GO:0031720) |
0.4 | 2.9 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.4 | 1.1 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.4 | 8.4 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.4 | 1.8 | GO:0035671 | enone reductase activity(GO:0035671) |
0.4 | 0.4 | GO:0019158 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.4 | 4.0 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.4 | 2.9 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.4 | 0.7 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
0.4 | 1.4 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.4 | 0.7 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.4 | 10.0 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.4 | 0.7 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.4 | 0.7 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.4 | 13.5 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.4 | 3.9 | GO:0005123 | death receptor binding(GO:0005123) |
0.4 | 1.1 | GO:0005534 | galactose binding(GO:0005534) |
0.4 | 5.3 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.4 | 4.6 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.4 | 0.7 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.4 | 0.7 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.4 | 1.8 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.3 | 2.4 | GO:0036122 | BMP binding(GO:0036122) |
0.3 | 1.0 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.3 | 2.8 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.3 | 2.8 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.3 | 1.4 | GO:0047105 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
0.3 | 1.0 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.3 | 1.0 | GO:0008390 | testosterone 16-alpha-hydroxylase activity(GO:0008390) |
0.3 | 0.3 | GO:0032557 | pyrimidine ribonucleotide binding(GO:0032557) |
0.3 | 5.2 | GO:0001848 | complement binding(GO:0001848) |
0.3 | 3.8 | GO:0031005 | filamin binding(GO:0031005) |
0.3 | 1.0 | GO:0015065 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.3 | 1.7 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.3 | 1.0 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.3 | 1.0 | GO:0019961 | interferon binding(GO:0019961) |
0.3 | 0.7 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.3 | 2.4 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.3 | 0.3 | GO:0033695 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
0.3 | 0.3 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.3 | 1.0 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.3 | 1.0 | GO:0008199 | ferric iron binding(GO:0008199) |
0.3 | 1.0 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.3 | 2.6 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.3 | 1.6 | GO:0031419 | cobalamin binding(GO:0031419) |
0.3 | 1.0 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.3 | 1.3 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.3 | 2.3 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.3 | 3.3 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.3 | 2.6 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.3 | 1.3 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.3 | 1.3 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.3 | 0.6 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.3 | 15.7 | GO:0044824 | integrase activity(GO:0008907) T/G mismatch-specific endonuclease activity(GO:0043765) retroviral integrase activity(GO:0044823) retroviral 3' processing activity(GO:0044824) |
0.3 | 3.5 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.3 | 1.0 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.3 | 2.9 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.3 | 3.8 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.3 | 0.9 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.3 | 0.6 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.3 | 0.9 | GO:0016801 | hydrolase activity, acting on ether bonds(GO:0016801) |
0.3 | 6.0 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.3 | 2.8 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
0.3 | 1.3 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.3 | 7.2 | GO:0017069 | snRNA binding(GO:0017069) |
0.3 | 1.6 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.3 | 1.2 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.3 | 7.1 | GO:0045309 | protein phosphorylated amino acid binding(GO:0045309) |
0.3 | 0.9 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.3 | 1.5 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
0.3 | 0.9 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.3 | 4.3 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.3 | 0.9 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.3 | 1.2 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.3 | 1.5 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.3 | 2.4 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.3 | 0.9 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.3 | 0.9 | GO:0055100 | adiponectin binding(GO:0055100) |
0.3 | 0.9 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.3 | 0.9 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
0.3 | 2.7 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.3 | 4.5 | GO:0032183 | SUMO binding(GO:0032183) |
0.3 | 2.7 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.3 | 2.6 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.3 | 0.6 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.3 | 3.2 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.3 | 0.6 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.3 | 0.9 | GO:0048030 | disaccharide binding(GO:0048030) |
0.3 | 0.6 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
0.3 | 25.8 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.3 | 0.6 | GO:0001846 | opsonin binding(GO:0001846) |
0.3 | 0.9 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.3 | 1.4 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
0.3 | 3.7 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.3 | 2.3 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.3 | 7.3 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.3 | 3.1 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.3 | 0.8 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.3 | 1.1 | GO:0004031 | aldehyde oxidase activity(GO:0004031) oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.3 | 3.9 | GO:0016594 | glycine binding(GO:0016594) |
0.3 | 0.6 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.3 | 0.6 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.3 | 4.7 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.3 | 1.4 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.3 | 0.3 | GO:0008142 | oxysterol binding(GO:0008142) |
0.3 | 3.3 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.3 | 0.8 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.3 | 0.8 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.3 | 1.1 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.3 | 2.2 | GO:0046972 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.3 | 0.3 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.3 | 0.5 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.3 | 0.8 | GO:0004359 | glutaminase activity(GO:0004359) |
0.3 | 0.5 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.3 | 1.3 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.3 | 1.3 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.3 | 3.2 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.3 | 22.9 | GO:0008175 | tRNA methyltransferase activity(GO:0008175) |
0.3 | 8.6 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.3 | 4.9 | GO:0034594 | phosphatidylinositol trisphosphate phosphatase activity(GO:0034594) |
0.3 | 0.5 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.3 | 2.3 | GO:0036222 | dITP diphosphatase activity(GO:0035870) XTP diphosphatase activity(GO:0036222) |
0.3 | 0.8 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.3 | 6.2 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.3 | 2.5 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.3 | 1.3 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.3 | 1.0 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.3 | 7.5 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.2 | 1.2 | GO:0015288 | porin activity(GO:0015288) |
0.2 | 1.2 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.2 | 1.0 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.2 | 1.2 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.2 | 1.0 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.2 | 2.0 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
0.2 | 1.2 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
0.2 | 0.7 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.2 | 1.7 | GO:0016679 | oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) |
0.2 | 6.8 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.2 | 0.2 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.2 | 4.8 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.2 | 1.2 | GO:1990405 | protein antigen binding(GO:1990405) |
0.2 | 2.7 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.2 | 1.2 | GO:0005113 | patched binding(GO:0005113) |
0.2 | 7.7 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.2 | 2.4 | GO:0004568 | chitinase activity(GO:0004568) |
0.2 | 1.0 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
0.2 | 0.5 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.2 | 5.0 | GO:0046915 | transition metal ion transmembrane transporter activity(GO:0046915) |
0.2 | 2.1 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.2 | 0.7 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.2 | 5.2 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.2 | 0.2 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
0.2 | 6.9 | GO:0016860 | intramolecular oxidoreductase activity(GO:0016860) |
0.2 | 0.5 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.2 | 0.5 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
0.2 | 3.1 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.2 | 0.7 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.2 | 0.5 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.2 | 0.9 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.2 | 3.8 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.2 | 0.7 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.2 | 0.9 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.2 | 6.2 | GO:0030145 | manganese ion binding(GO:0030145) |
0.2 | 0.7 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.2 | 1.4 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.2 | 3.4 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.2 | 1.3 | GO:0048156 | tau protein binding(GO:0048156) |
0.2 | 2.9 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.2 | 1.6 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.2 | 2.0 | GO:0044548 | S100 protein binding(GO:0044548) |
0.2 | 1.6 | GO:0033691 | sialic acid binding(GO:0033691) |
0.2 | 31.0 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
0.2 | 4.5 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.2 | 3.5 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.2 | 1.5 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.2 | 0.7 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
0.2 | 0.4 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
0.2 | 0.9 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.2 | 1.5 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.2 | 2.0 | GO:0031491 | nucleosome binding(GO:0031491) |
0.2 | 2.6 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.2 | 1.7 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
0.2 | 2.8 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.2 | 0.2 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.2 | 0.9 | GO:0102344 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
0.2 | 1.5 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.2 | 0.6 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.2 | 0.8 | GO:0015232 | heme transporter activity(GO:0015232) |
0.2 | 2.5 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.2 | 0.4 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.2 | 0.6 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.2 | 2.7 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.2 | 5.8 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.2 | 1.2 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.2 | 0.6 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.2 | 1.0 | GO:0008251 | tRNA-specific adenosine deaminase activity(GO:0008251) |
0.2 | 2.5 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.2 | 0.2 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.2 | 0.6 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.2 | 1.0 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.2 | 1.0 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.2 | 2.4 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.2 | 0.8 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.2 | 0.6 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.2 | 0.8 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.2 | 1.0 | GO:0052758 | 4-methyloctanoyl-CoA dehydrogenase activity(GO:0034580) naphthyl-2-methyl-succinyl-CoA dehydrogenase activity(GO:0034845) 2-methylhexanoyl-CoA dehydrogenase activity(GO:0034916) propionyl-CoA dehydrogenase activity(GO:0043820) thiol-driven fumarate reductase activity(GO:0043830) coenzyme F420-dependent 2,4,6-trinitrophenol reductase activity(GO:0052758) coenzyme F420-dependent 2,4,6-trinitrophenol hydride reductase activity(GO:0052759) coenzyme F420-dependent 2,4-dinitrophenol reductase activity(GO:0052760) |
0.2 | 3.4 | GO:0043531 | ADP binding(GO:0043531) |
0.2 | 0.4 | GO:0016936 | galactoside binding(GO:0016936) |
0.2 | 3.0 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.2 | 1.6 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
0.2 | 1.0 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.2 | 0.2 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.2 | 0.6 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.2 | 0.8 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.2 | 1.2 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.2 | 1.2 | GO:0034046 | poly(G) binding(GO:0034046) |
0.2 | 0.6 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.2 | 1.8 | GO:0017166 | vinculin binding(GO:0017166) |
0.2 | 0.8 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.2 | 5.1 | GO:0045502 | dynein binding(GO:0045502) |
0.2 | 1.0 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.2 | 1.8 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.2 | 0.6 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.2 | 3.9 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.2 | 1.0 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.2 | 1.5 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.2 | 0.8 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.2 | 1.2 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.2 | 4.2 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.2 | 6.7 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.2 | 3.9 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.2 | 0.4 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.2 | 6.5 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.2 | 0.4 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.2 | 1.1 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.2 | 0.6 | GO:0001031 | RNA polymerase III regulatory region DNA binding(GO:0001016) RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) RNA polymerase III type 3 promoter DNA binding(GO:0001032) 5S rDNA binding(GO:0080084) |
0.2 | 0.5 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.2 | 0.4 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
0.2 | 0.5 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) |
0.2 | 0.9 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.2 | 1.6 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.2 | 0.5 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.2 | 0.4 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.2 | 3.0 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.2 | 1.7 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.2 | 0.2 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.2 | 2.3 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.2 | 0.3 | GO:0001962 | alpha-1,3-galactosyltransferase activity(GO:0001962) |
0.2 | 10.8 | GO:0004519 | endonuclease activity(GO:0004519) |
0.2 | 1.0 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.2 | 0.9 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.2 | 0.3 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.2 | 0.7 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.2 | 1.0 | GO:0015321 | sodium:phosphate symporter activity(GO:0005436) sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.2 | 1.0 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.2 | 0.8 | GO:0015197 | peptide transporter activity(GO:0015197) |
0.2 | 1.0 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.2 | 0.5 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.2 | 0.5 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.2 | 1.6 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.2 | 2.6 | GO:0050661 | NADP binding(GO:0050661) |
0.2 | 0.6 | GO:0031544 | peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.2 | 1.6 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.2 | 0.3 | GO:0016303 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) |
0.2 | 0.6 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
0.2 | 0.5 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.2 | 0.3 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.2 | 1.7 | GO:0048038 | quinone binding(GO:0048038) |
0.2 | 1.2 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.2 | 0.2 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
0.2 | 8.8 | GO:0008186 | ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.2 | 0.3 | GO:0015186 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
0.2 | 0.6 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.2 | 1.2 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.2 | 1.2 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.2 | 1.1 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.2 | 0.9 | GO:0031996 | thioesterase binding(GO:0031996) |
0.2 | 2.0 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.1 | 0.1 | GO:0016653 | oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor(GO:0016653) |
0.1 | 2.7 | GO:0030552 | cAMP binding(GO:0030552) |
0.1 | 0.3 | GO:0097016 | L27 domain binding(GO:0097016) |
0.1 | 0.9 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.1 | 6.9 | GO:0019003 | GDP binding(GO:0019003) |
0.1 | 0.1 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.1 | 0.1 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.1 | 0.1 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.1 | 2.0 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 0.1 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.1 | 0.4 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.1 | 0.7 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.1 | 0.3 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.1 | 6.7 | GO:0051087 | chaperone binding(GO:0051087) |
0.1 | 0.3 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.1 | 0.3 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.1 | 0.4 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.1 | 0.3 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.1 | 1.3 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.1 | 4.4 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.1 | 7.3 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.1 | 0.1 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.1 | 0.1 | GO:1990459 | transferrin receptor binding(GO:1990459) |
0.1 | 0.4 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.1 | 12.4 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.1 | 2.9 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.1 | 0.8 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.1 | 0.4 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.1 | 0.7 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.1 | 10.7 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.1 | 0.3 | GO:0000339 | RNA cap binding(GO:0000339) |
0.1 | 4.6 | GO:0016763 | transferase activity, transferring pentosyl groups(GO:0016763) |
0.1 | 0.3 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.1 | 1.0 | GO:0043274 | phospholipase binding(GO:0043274) |
0.1 | 0.3 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.1 | 0.5 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.1 | 0.7 | GO:0070990 | snRNP binding(GO:0070990) |
0.1 | 0.3 | GO:0019808 | polyamine binding(GO:0019808) |
0.1 | 1.2 | GO:0071949 | FAD binding(GO:0071949) |
0.1 | 0.1 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.1 | 0.5 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.1 | 4.2 | GO:0003823 | antigen binding(GO:0003823) |
0.1 | 0.9 | GO:0034784 | pivalyl-CoA mutase activity(GO:0034784) o-hydroxylaminobenzoate mutase activity(GO:0034951) lupeol synthase activity(GO:0042299) beta-amyrin synthase activity(GO:0042300) baruol synthase activity(GO:0080011) |
0.1 | 2.1 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.1 | 0.3 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.1 | 6.0 | GO:0005518 | collagen binding(GO:0005518) |
0.1 | 0.3 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.1 | 0.4 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.1 | 1.0 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.1 | 7.1 | GO:0008565 | protein transporter activity(GO:0008565) |
0.1 | 0.1 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.1 | 0.3 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.1 | 0.3 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.1 | 0.1 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.1 | 0.5 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.1 | 0.5 | GO:0052796 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.1 | 0.3 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.1 | 0.5 | GO:0038100 | nodal binding(GO:0038100) |
0.1 | 2.6 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.1 | 0.5 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.1 | 2.1 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.1 | 0.9 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.1 | 0.2 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
0.1 | 1.0 | GO:0001618 | virus receptor activity(GO:0001618) |
0.1 | 0.6 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.1 | 0.7 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
0.1 | 1.5 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.1 | 0.1 | GO:0061733 | peptide-lysine-N-acetyltransferase activity(GO:0061733) |
0.1 | 0.6 | GO:0015922 | aspartate oxidase activity(GO:0015922) D-lysine oxidase activity(GO:0043912) |
0.1 | 0.5 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.1 | 0.4 | GO:0002046 | opsin binding(GO:0002046) |
0.1 | 1.0 | GO:0030332 | cyclin binding(GO:0030332) |
0.1 | 0.1 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.1 | 0.1 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.1 | 1.8 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.1 | 2.9 | GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) |
0.1 | 0.3 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.1 | 0.2 | GO:0034452 | dynactin binding(GO:0034452) |
0.1 | 2.3 | GO:0097472 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.1 | 0.1 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
0.1 | 0.4 | GO:0015925 | galactosidase activity(GO:0015925) |
0.1 | 1.5 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.1 | 2.5 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.1 | 1.0 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.1 | 3.6 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.1 | 0.3 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.1 | 0.2 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.1 | 0.3 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.1 | 2.8 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.1 | 0.9 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.1 | 0.4 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.1 | 0.4 | GO:0098505 | single-stranded telomeric DNA binding(GO:0043047) G-rich strand telomeric DNA binding(GO:0098505) |
0.1 | 0.2 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.1 | 0.4 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.1 | 0.3 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.1 | 0.3 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.1 | 8.1 | GO:0042393 | histone binding(GO:0042393) |
0.1 | 0.8 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.1 | 4.3 | GO:0004702 | receptor signaling protein serine/threonine kinase activity(GO:0004702) |
0.1 | 0.3 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.1 | 3.4 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.1 | 0.1 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.1 | 6.2 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.1 | 0.4 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.1 | 8.0 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.1 | 0.1 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.1 | 0.4 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.1 | 0.2 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.1 | 0.1 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.1 | 1.4 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.1 | 1.3 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.1 | 0.4 | GO:0050543 | icosatetraenoic acid binding(GO:0050543) |
0.1 | 0.1 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.1 | 0.3 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.1 | 0.5 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.1 | 7.1 | GO:0101005 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.1 | 0.2 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.1 | 0.2 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.1 | 0.9 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.1 | 7.6 | GO:0003713 | transcription coactivator activity(GO:0003713) |
0.1 | 0.3 | GO:0043199 | sulfate binding(GO:0043199) |
0.1 | 0.2 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.1 | 0.3 | GO:0032052 | bile acid binding(GO:0032052) |
0.1 | 1.0 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.1 | 0.8 | GO:0072349 | modified amino acid transmembrane transporter activity(GO:0072349) |
0.1 | 0.6 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.1 | 0.4 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.1 | 0.4 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
0.1 | 1.3 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.1 | 1.3 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.1 | 0.5 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.1 | 0.3 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.1 | 0.2 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.1 | 0.3 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.1 | 0.4 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.1 | 4.7 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.1 | 0.3 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.1 | 0.3 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.1 | 0.6 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.1 | 0.3 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.1 | 0.3 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.1 | 0.1 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
0.1 | 2.2 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.1 | 15.4 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.1 | 0.1 | GO:0008649 | rRNA methyltransferase activity(GO:0008649) rRNA (uridine) methyltransferase activity(GO:0016436) |
0.1 | 0.4 | GO:0043236 | laminin binding(GO:0043236) |
0.1 | 1.7 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.1 | 0.2 | GO:0032451 | demethylase activity(GO:0032451) |
0.1 | 0.5 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.1 | 0.3 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.1 | 0.2 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
0.1 | 0.3 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.1 | 0.3 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.1 | 0.3 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.1 | 0.3 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.1 | 1.4 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.1 | 0.2 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
0.1 | 0.5 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.1 | 0.1 | GO:0030957 | Tat protein binding(GO:0030957) |
0.1 | 0.2 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.1 | 4.1 | GO:0035326 | enhancer binding(GO:0035326) |
0.1 | 1.3 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.1 | 1.2 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.1 | 0.2 | GO:1990254 | keratin filament binding(GO:1990254) |
0.1 | 0.2 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.1 | 2.3 | GO:0051117 | ATPase binding(GO:0051117) |
0.1 | 0.1 | GO:0019213 | deacetylase activity(GO:0019213) |
0.1 | 0.5 | GO:0042469 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.1 | 0.5 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.1 | 0.3 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
0.1 | 2.9 | GO:0008135 | translation factor activity, RNA binding(GO:0008135) |
0.1 | 0.2 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.1 | 5.5 | GO:0000287 | magnesium ion binding(GO:0000287) |
0.1 | 0.6 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
0.1 | 0.3 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.1 | 0.2 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.1 | 0.6 | GO:0003796 | lysozyme activity(GO:0003796) |
0.1 | 1.0 | GO:0015928 | fucosidase activity(GO:0015928) |
0.1 | 0.3 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.1 | 2.3 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.1 | 0.9 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.1 | 0.3 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.1 | 0.8 | GO:0099589 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.1 | 0.2 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.1 | 1.0 | GO:0019843 | rRNA binding(GO:0019843) |
0.1 | 0.1 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
0.1 | 11.7 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.1 | 0.4 | GO:0052724 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.1 | 1.7 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.1 | 1.1 | GO:0016209 | antioxidant activity(GO:0016209) |
0.1 | 1.1 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.1 | 0.2 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.1 | 1.3 | GO:0004518 | nuclease activity(GO:0004518) |
0.1 | 0.1 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) |
0.1 | 1.7 | GO:0016417 | S-acyltransferase activity(GO:0016417) |
0.1 | 1.3 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.1 | 0.1 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.1 | 0.3 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.1 | 1.4 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.1 | 0.2 | GO:0008430 | selenium binding(GO:0008430) |
0.1 | 0.3 | GO:0031014 | troponin T binding(GO:0031014) |
0.1 | 0.1 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.1 | 0.3 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.1 | 0.2 | GO:0032813 | tumor necrosis factor receptor superfamily binding(GO:0032813) |
0.1 | 0.2 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.1 | 3.4 | GO:0016791 | phosphatase activity(GO:0016791) |
0.1 | 0.2 | GO:0048495 | Roundabout binding(GO:0048495) |
0.1 | 0.1 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.1 | 0.2 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.1 | 0.3 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.1 | 0.6 | GO:0051287 | NAD binding(GO:0051287) |
0.1 | 0.4 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.1 | 0.1 | GO:0034618 | arginine binding(GO:0034618) |
0.1 | 1.5 | GO:0002039 | p53 binding(GO:0002039) |
0.1 | 0.1 | GO:0000182 | rDNA binding(GO:0000182) |
0.1 | 0.2 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.1 | 0.1 | GO:0031559 | oxidosqualene cyclase activity(GO:0031559) |
0.1 | 0.1 | GO:0003916 | DNA topoisomerase activity(GO:0003916) |
0.1 | 0.9 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 0.2 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.1 | 0.2 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.1 | 0.6 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.1 | 2.5 | GO:0042626 | ATPase activity, coupled to transmembrane movement of substances(GO:0042626) |
0.1 | 0.3 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.1 | 0.2 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.1 | 0.2 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.1 | 2.0 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.1 | 1.5 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.1 | 5.4 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.1 | 0.1 | GO:0042287 | MHC protein binding(GO:0042287) |
0.1 | 0.2 | GO:0030021 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.1 | 8.6 | GO:0005125 | cytokine activity(GO:0005125) |
0.1 | 0.1 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.1 | 0.1 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.1 | 0.4 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.1 | 0.2 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.1 | 1.9 | GO:0005506 | iron ion binding(GO:0005506) |
0.0 | 1.9 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.2 | GO:0071814 | lipoprotein particle binding(GO:0071813) protein-lipid complex binding(GO:0071814) |
0.0 | 0.2 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.0 | 0.1 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.0 | 0.0 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.0 | 0.1 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
0.0 | 0.8 | GO:0016675 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 0.8 | GO:0004386 | helicase activity(GO:0004386) |
0.0 | 0.3 | GO:0031386 | protein tag(GO:0031386) |
0.0 | 0.1 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.0 | 0.1 | GO:0035197 | siRNA binding(GO:0035197) |
0.0 | 0.0 | GO:0008061 | chitin binding(GO:0008061) |
0.0 | 0.8 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
0.0 | 0.2 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.0 | 0.1 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.0 | 20.1 | GO:0044822 | poly(A) RNA binding(GO:0044822) |
0.0 | 1.2 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
0.0 | 0.1 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.0 | 1.4 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.0 | 0.1 | GO:0005522 | profilin binding(GO:0005522) |
0.0 | 0.0 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.0 | 0.0 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.0 | 0.8 | GO:0042165 | neurotransmitter binding(GO:0042165) |
0.0 | 0.0 | GO:0016972 | thiol oxidase activity(GO:0016972) |
0.0 | 0.0 | GO:0000009 | alpha-1,6-mannosyltransferase activity(GO:0000009) |
0.0 | 0.0 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
0.0 | 0.0 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.0 | 0.0 | GO:0015149 | hexose transmembrane transporter activity(GO:0015149) |
0.0 | 0.4 | GO:0051213 | dioxygenase activity(GO:0051213) |
0.0 | 0.0 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.0 | 0.1 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.0 | 0.1 | GO:0043515 | kinetochore binding(GO:0043515) |
0.0 | 0.0 | GO:0030228 | lipoprotein particle receptor activity(GO:0030228) |
0.0 | 0.0 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.0 | 0.0 | GO:0043559 | insulin binding(GO:0043559) |
0.0 | 0.1 | GO:0051184 | cofactor transporter activity(GO:0051184) coenzyme transporter activity(GO:0051185) |
0.0 | 0.0 | GO:0005501 | retinoid binding(GO:0005501) |
0.0 | 0.1 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.0 | 0.1 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.0 | 0.1 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.0 | 0.1 | GO:0070061 | fructose binding(GO:0070061) |
0.0 | 0.1 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.0 | 0.1 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.0 | 0.1 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.0 | 0.0 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.0 | 0.2 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.0 | 0.1 | GO:0005499 | vitamin D binding(GO:0005499) |
0.0 | 0.0 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.0 | 0.1 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.0 | 0.1 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.0 | 0.2 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.0 | 0.7 | GO:0060090 | binding, bridging(GO:0060090) |
0.0 | 0.1 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.0 | 0.1 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.0 | 0.0 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.0 | 0.3 | GO:0038024 | cargo receptor activity(GO:0038024) |
0.0 | 0.0 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.0 | 0.0 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.0 | 0.4 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.0 | 0.0 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.0 | 0.0 | GO:0032404 | mismatch repair complex binding(GO:0032404) |
0.0 | 0.2 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.0 | 0.0 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.0 | 0.3 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.0 | 0.2 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.0 | 0.3 | GO:0008170 | N-methyltransferase activity(GO:0008170) |
0.0 | 0.4 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.0 | 1.6 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.0 | 0.2 | GO:0035257 | nuclear hormone receptor binding(GO:0035257) |
0.0 | 0.0 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.0 | 0.3 | GO:0016876 | ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.0 | 0.3 | GO:0030414 | peptidase inhibitor activity(GO:0030414) |
0.0 | 0.1 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.0 | 0.0 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.0 | 0.0 | GO:0031781 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.0 | 0.0 | GO:0030249 | cyclase regulator activity(GO:0010851) guanylate cyclase regulator activity(GO:0030249) |
0.0 | 11.7 | GO:0004984 | olfactory receptor activity(GO:0004984) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.8 | 3.7 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.9 | 28.0 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.9 | 22.5 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.9 | 0.9 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.8 | 2.4 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.7 | 9.9 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.6 | 25.0 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.6 | 10.6 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.5 | 8.8 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.5 | 6.4 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.5 | 2.5 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.5 | 5.0 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.5 | 2.9 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.5 | 12.9 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.4 | 9.1 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.4 | 7.0 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.4 | 6.0 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.4 | 3.6 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.4 | 4.3 | PID EPO PATHWAY | EPO signaling pathway |
0.4 | 5.0 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.4 | 7.3 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.4 | 2.3 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.4 | 9.4 | PID AURORA A PATHWAY | Aurora A signaling |
0.4 | 9.2 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.4 | 6.6 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.4 | 4.0 | PID IGF1 PATHWAY | IGF1 pathway |
0.4 | 0.4 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.4 | 1.1 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.4 | 5.6 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.3 | 10.8 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.3 | 4.1 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.3 | 3.6 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.3 | 12.9 | PID CDC42 PATHWAY | CDC42 signaling events |
0.3 | 9.3 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.3 | 7.4 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.3 | 0.5 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.3 | 5.1 | PID MYC PATHWAY | C-MYC pathway |
0.3 | 1.1 | PID FOXO PATHWAY | FoxO family signaling |
0.3 | 0.8 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.3 | 0.3 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.2 | 6.2 | PID BARD1 PATHWAY | BARD1 signaling events |
0.2 | 3.0 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.2 | 0.7 | PID ALK2 PATHWAY | ALK2 signaling events |
0.2 | 6.4 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.2 | 11.1 | PID P73PATHWAY | p73 transcription factor network |
0.2 | 2.1 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.2 | 1.2 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.2 | 1.6 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.2 | 5.1 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.2 | 6.9 | PID P53 REGULATION PATHWAY | p53 pathway |
0.2 | 0.5 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.2 | 3.2 | PID RHOA PATHWAY | RhoA signaling pathway |
0.2 | 0.7 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.2 | 0.7 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.2 | 3.8 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.2 | 3.9 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.2 | 2.6 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.2 | 9.3 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.2 | 7.7 | PID E2F PATHWAY | E2F transcription factor network |
0.2 | 6.2 | PID PLK1 PATHWAY | PLK1 signaling events |
0.2 | 5.4 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.2 | 4.0 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.2 | 13.0 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.2 | 1.3 | PID IFNG PATHWAY | IFN-gamma pathway |
0.2 | 4.1 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.2 | 0.9 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.2 | 1.1 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.2 | 1.5 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.2 | 0.3 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.2 | 1.3 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.2 | 4.4 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.2 | 1.4 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.2 | 5.8 | PID NOTCH PATHWAY | Notch signaling pathway |
0.1 | 0.3 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.1 | 2.8 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.1 | 0.4 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 1.3 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.1 | 1.1 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.1 | 1.8 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.1 | 3.7 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.1 | 1.2 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.1 | 2.4 | PID AURORA B PATHWAY | Aurora B signaling |
0.1 | 0.8 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.1 | 1.0 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.1 | 2.4 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.1 | 0.8 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.1 | 2.1 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.1 | 0.5 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 0.4 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.1 | 3.5 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.1 | 0.5 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.1 | 0.6 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 0.1 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.1 | 2.2 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.1 | 1.5 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.1 | 1.8 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.1 | 4.4 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.1 | 0.9 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.1 | 1.4 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.1 | 0.7 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 0.1 | PID REELIN PATHWAY | Reelin signaling pathway |
0.1 | 0.4 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.1 | 1.1 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.1 | 0.1 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.1 | 0.2 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.1 | 0.1 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.1 | 11.0 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 0.1 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.1 | 0.8 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 0.5 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.1 | 0.6 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 1.0 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.0 | 0.0 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.0 | 1.4 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.0 | 0.3 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.0 | 0.0 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.0 | 0.0 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.0 | 5.4 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.1 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.0 | 0.5 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.0 | 0.0 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.0 | 0.5 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.0 | 0.1 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.2 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.0 | 0.5 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 0.3 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.0 | 0.0 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.0 | 0.1 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.0 | 0.5 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.0 | 0.0 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.0 | 0.2 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.0 | 0.0 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.0 | 0.0 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.0 | 0.0 | PID INSULIN PATHWAY | Insulin Pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.8 | 22.9 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
1.4 | 13.6 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
1.2 | 1.2 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
1.1 | 11.4 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
1.0 | 9.2 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
1.0 | 12.0 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.9 | 1.8 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.9 | 0.9 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
0.9 | 8.6 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.9 | 13.8 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.8 | 7.5 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.8 | 5.6 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.8 | 13.2 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.8 | 10.5 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.7 | 11.1 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.7 | 12.6 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.6 | 14.4 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.6 | 1.8 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.6 | 4.4 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
0.5 | 1.1 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.5 | 4.7 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.5 | 4.6 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.5 | 11.7 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.5 | 2.5 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.5 | 3.5 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.5 | 11.6 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.5 | 8.5 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.5 | 11.3 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.5 | 3.4 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.5 | 3.9 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.5 | 6.0 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.4 | 10.2 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.4 | 1.3 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.4 | 5.6 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.4 | 0.9 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.4 | 5.5 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.4 | 3.8 | REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
0.4 | 12.8 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.4 | 5.7 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.4 | 2.0 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.4 | 4.4 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.4 | 18.1 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.4 | 3.1 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.4 | 10.4 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.4 | 11.1 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.4 | 5.4 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.4 | 4.1 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.4 | 4.9 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.4 | 6.0 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.4 | 0.7 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.4 | 1.5 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.4 | 2.5 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.4 | 0.4 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.3 | 3.8 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.3 | 1.0 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.3 | 2.1 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.3 | 3.8 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.3 | 1.4 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.3 | 4.6 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.3 | 3.3 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.3 | 2.6 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.3 | 3.9 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.3 | 4.5 | REACTOME PI METABOLISM | Genes involved in PI Metabolism |
0.3 | 4.4 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.3 | 43.7 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.3 | 0.9 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.3 | 2.5 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.3 | 0.3 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.3 | 5.3 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.3 | 4.3 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.3 | 2.2 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.3 | 0.6 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.3 | 0.3 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.3 | 3.6 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.3 | 5.3 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.3 | 6.5 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.3 | 2.3 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.3 | 30.7 | REACTOME FATTY ACID TRIACYLGLYCEROL AND KETONE BODY METABOLISM | Genes involved in Fatty acid, triacylglycerol, and ketone body metabolism |
0.3 | 13.6 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.3 | 1.1 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.3 | 6.7 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.3 | 5.3 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.3 | 3.3 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.3 | 3.8 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.3 | 7.2 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.3 | 4.0 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.3 | 7.9 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.3 | 3.9 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.3 | 2.8 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.3 | 2.3 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.2 | 5.5 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.2 | 2.4 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
0.2 | 0.5 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.2 | 1.8 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.2 | 2.0 | REACTOME CDT1 ASSOCIATION WITH THE CDC6 ORC ORIGIN COMPLEX | Genes involved in CDT1 association with the CDC6:ORC:origin complex |
0.2 | 0.5 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
0.2 | 0.5 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.2 | 7.1 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.2 | 4.2 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.2 | 2.2 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.2 | 4.1 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.2 | 2.6 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.2 | 8.0 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.2 | 4.0 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
0.2 | 1.4 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.2 | 0.8 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.2 | 2.6 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.2 | 3.3 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.2 | 3.1 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.2 | 1.6 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.2 | 1.6 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.2 | 1.4 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.2 | 0.6 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.2 | 1.3 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.2 | 2.7 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.2 | 2.9 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.2 | 7.0 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.2 | 2.4 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
0.2 | 8.3 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.2 | 0.7 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
0.2 | 1.3 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.2 | 1.6 | REACTOME E2F MEDIATED REGULATION OF DNA REPLICATION | Genes involved in E2F mediated regulation of DNA replication |
0.2 | 0.9 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.2 | 5.0 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.2 | 3.1 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.2 | 4.1 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.2 | 2.9 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.2 | 1.0 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.2 | 5.0 | REACTOME RNA POL II TRANSCRIPTION | Genes involved in RNA Polymerase II Transcription |
0.2 | 1.0 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.2 | 1.8 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.2 | 1.5 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.2 | 3.3 | REACTOME BIOLOGICAL OXIDATIONS | Genes involved in Biological oxidations |
0.2 | 0.8 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
0.2 | 9.3 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.2 | 1.7 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.2 | 1.2 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.1 | 2.1 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.1 | 1.3 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.1 | 0.9 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.1 | 0.1 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
0.1 | 0.3 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.1 | 1.5 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.1 | 0.1 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.1 | 0.1 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.1 | 0.1 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.1 | 1.5 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.1 | 1.1 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.1 | 0.8 | REACTOME RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES | Genes involved in Recruitment of mitotic centrosome proteins and complexes |
0.1 | 1.4 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.1 | 0.7 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.1 | 1.7 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
0.1 | 1.4 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.1 | 0.5 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.1 | 0.4 | REACTOME MITOTIC G2 G2 M PHASES | Genes involved in Mitotic G2-G2/M phases |
0.1 | 1.6 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.1 | 0.6 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.1 | 0.7 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.1 | 0.7 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.1 | 1.5 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.1 | 6.4 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.1 | 0.9 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 1.6 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.1 | 1.0 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.1 | 1.7 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.1 | 4.9 | REACTOME SIGNALING BY NOTCH | Genes involved in Signaling by NOTCH |
0.1 | 3.8 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.1 | 1.3 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.1 | 0.5 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.1 | 1.4 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.1 | 2.9 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 6.6 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.1 | 2.5 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.1 | 0.1 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.1 | 1.1 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.1 | 0.8 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.1 | 0.8 | REACTOME POL SWITCHING | Genes involved in Polymerase switching |
0.1 | 1.4 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.1 | 1.0 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.1 | 0.5 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.1 | 1.9 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.1 | 3.1 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.1 | 1.8 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.1 | 0.6 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 0.2 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
0.1 | 7.2 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.1 | 0.9 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.1 | 0.2 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
0.1 | 0.7 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.1 | 1.6 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.1 | 2.9 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.1 | 0.3 | REACTOME CELL CYCLE CHECKPOINTS | Genes involved in Cell Cycle Checkpoints |
0.1 | 0.1 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.1 | 0.1 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.1 | 0.7 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.1 | 2.6 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 4.1 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.1 | 1.2 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 0.2 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.1 | 0.8 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.1 | 1.5 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.1 | 0.1 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.1 | 0.1 | REACTOME 3 UTR MEDIATED TRANSLATIONAL REGULATION | Genes involved in 3' -UTR-mediated translational regulation |
0.1 | 0.7 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.1 | 0.9 | REACTOME DIABETES PATHWAYS | Genes involved in Diabetes pathways |
0.1 | 0.9 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.1 | 0.1 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.1 | 1.2 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.1 | 0.4 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.1 | 2.1 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.1 | 0.5 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.1 | 0.7 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.1 | 1.5 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 0.6 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.0 | 0.1 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.0 | 0.1 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.0 | 0.4 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.0 | 0.5 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.0 | 0.5 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.0 | 0.1 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
0.0 | 0.7 | REACTOME SIGNALING BY ILS | Genes involved in Signaling by Interleukins |
0.0 | 0.0 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.0 | 0.3 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.0 | 0.5 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.0 | 0.1 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.0 | 0.3 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.0 | 1.1 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 0.3 | REACTOME SYNTHESIS OF DNA | Genes involved in Synthesis of DNA |
0.0 | 0.2 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.0 | 0.1 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.0 | 3.9 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 0.1 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.0 | 1.5 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.3 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.0 | 0.2 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.0 | 0.2 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.0 | 0.0 | REACTOME CD28 CO STIMULATION | Genes involved in CD28 co-stimulation |
0.0 | 0.1 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.0 | 0.0 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.0 | 0.1 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |